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Abstract

Efforts to create a mycolactone-negative mutant of Mycobacterium u/cerans via
transposon mutagenesis were undertaken to elucidate the genes involved in the
production of this toxin. Though only five PCR-confirmed insertion mutants were
produced, one of these, 1615:tnp6w, was confirmed to be deficient in mycolactone
production via thin-layer chromatography (TLC) of acetone soluble lipids (ASLs),
cytopathicity assay of culture filtrate on L929 fibroblasts, and mass spectroscopy of
ASLs. Using nested-PCR, it was determined that the transposon insertion of 1615:tnp6w
had occurred in a region of DNA containing a gene 97% identical to the M marinum
ferric uptake regulator homolog (FurA) gene and 89% identical to the furA gene of M
tuberculosis. The region of M ulcerans homologous to the already characterized M
marinum furA gene was cloned; and, the construct was used in complementation studies
in an attempt to confirm the role of FurA in mycolactone production. Transformation of
the 1615:tnp6w mutant with the construct containing furA failed to restore mycolactone
production. The failure of the complementation of the furA gene to restore mycolactone
production was explained via PCR studies which revealed a spontaneous deletion in the
thioesterase II gene recently identified to be required for mycolactone production.
Secondly, experiments aimed at developing an efficient transformation protocol for M
ulcerans were undertaken. In an effort to determine the effect of temperature on the
transformation efficiency of M ulcerans via electroporation, electroporation experiments
were performed on M ulcerans 1615 grown in Middlebrook 7H9 with 10% oleic acid
albumin-dextrose-complex supplement (M7H9 + OADC). Log phase cultures were
111

harvested, washed with 10% glycerol, and apportioned into 60 µL aliquots. Aliquots
were briefly held at room temperature, 37t, 40t, or 45t before electroporation in the
presence of 1 µg of pPR27Hl, a hygromycin B resistance conveying plasmid. After 8
weeks, colonies were counted to calculate transformation efficiencies. To determine if
the presence of mycolactone affects electroporation efficiency, this experiment was
repeated with M ulcerans grown in Modified Reid's synthetic medium and M ulcerans
grown in Sauton' s synthetic medium, both media which are thought to promote a
decreased production of mycolactone; M ulcerans grown in Middlebrook 7H9 with 20%
oleic acid-albumin-dextrose-complex supplement (M7H9 + 2[OADC]), which is believed
to foster an increased production of mycolactone; and, a polyketide synthase (PKS)
knock-out mutant of M ulcerans (mutant 115) which does not produce mycolactone
grown in M7H9 + OADC. Though electroporation of M ulcerans grown in M7H9 +
OADC produced transformants reliably (regardless of the temperature of the cell at the
time of electroporation); the transformation efficiencies were not high and, there was no
significant difference in the transformation efficiencies obtained by cells exposed to
different temperatures before electroporation. However, an additional experiment,
demonstrated that these cells exposed to 55t for the same amount of time prior to
electroporation did have a modest but significant increase in transformation efficiency. A
similar increase in transformation efficiency was obtained when M ulcerans grown in
M7H9 + 2[OADC] was electroporated after incubation at the lower temperature of 45t.
In an additional experiment, the fast growing M fortuitum grown in M7H9 + OADC had
the highest transformation efficiency when electroporated after incubation at 45t.
Finally, though the natural reservoir of M ulcerans is unknown, Buruli ulcer disease
lV

seems to be associated with water. For this reason, experiments aimed at investigating
aquatic snails, also associated with water in Buruli ulcer endemic regions, as a
component of the ecological niche of M ulcerans were undertaken. Snails of the species
Biomphalaria glabrata are intermediate hosts of the schistosome species Schistosoma
mansoni; and, it is feasible that M ulcerans could associate with cercariae, the

schistosomal life stage infectious to humans, infecting humans through the wound caused
by the cercaria entering its human host. Through various experiments, both healthy
Biomphalaria glabrata and Schistosoma mansoni-infected Biomphalaria glabrata were

exposed to M ulcerans and examined for M ulcerans infection via PCR and plating of
ground tissue. While PCR analysis demonstrated a possible association between M
ulcerans and healthy snails; M ulcerans was not recovered by plating of the tissue of

snails exposed to the bacteria during any of three infection experiments. Hystological
sectioning of snail tissue yielded no reliable data.
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I. Literature Review

Clinical Presentation of Buruli Ulcer Disease

Mycobacterium ulcerans is the causative agent of the necrotizing skin disease
Buruli ulcer, the third most common mycobacterial disease of non-immunocompromised
people (81). For reasons not fully understood, Buruli ulcer can present in ways unique to
different endemic regions. In Africa, the disease usually begins as a small subcutaneous
mobile nodule measuring 1-2 cm in diameter (19, 31). In Australia, the disease most
commonly begins as an intradermal papule but may also be first noticed as an edematous
limb, a characteristic of necrotizing panniculitis (31, 35). Other preulcerative lesions
that may present include more localized edema and plaques-irregularly shaped
indurated patches of skin (81). These nonulcerative stages of the disease are generally
painless; however, though not common, they may itch (19). Subcutaneous calcification
may also occur (12, 31, 76). The first (nonulcerative) stage of Buruli ulcer may persist
for 1 or 2 months, after which the ulcer characteristic of this disease begins to form,
extending 15 cm or more (19) (Figure 1).
After the second (ulcerative) stage of the disease ensues, necrosis of the
subcutaneous fat along with vascular damage causes the skin overlying the ulcerative
area to die and slough off, producing secondary ulceration of the skin with a distinct
undermined edge (81) (Figure 2). If untreated, the ulceration may progress to involve an
entire limb or up to 15% of the body surface (23). Though rare, extensive ulceration can
result in osteomyelitis and even autoamputation. Ulcers that begin to heal contain
granulomatous tissue at their edges and may be said to have progressed to stage 3 of the
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Figure 1. The progression of the Buruli ulcer lesion to the ulcerative stage.
(Adapted from van der Werff, et al., 1999.)
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Figure 2. Ulcerative lesion of Buruli ulcer (stage 2) on an arm, leg, and hand.
(Adapted from Buruli ulcer: Diagnosis ofMycobacterium ulcerans Disease, WHO

2001.)

3

disease; while, those who have been debilitated by the disease even after the disease has
healed may be said to be in stage 4 of the disease (70). Though it is thought that massive
ulcers may cause systemic effects, ordinarily there are no effects beyond the region of the
ulcer (19). It is rare that Buruli ulcer causes pain or occurs in more than one site on the
body. Some ulcers may heal spontaneously, doing so slowly over months or years.
There is anecdotal evidence that patients with such spontaneously healing ulcers develop
a positive tuberculin skin test; while, those with ulcers which do not spontaneously heal
remain negative with regard to the tuberculin skin test (81). However, upon
histopathological examination, there appears to be a lack of a host inflammatory response
or granuloma formation at the site of the ulcer (12, 33, 76). Unlike other mycobacteria,
M ulcerans is rarely found inside macrophages. M ulcerans can be found in the ulcer
only in extracellular foci from which the necrosis extends well into areas from which
bacteria can not be isolated.
One study has shown that of the Buruli ulcer patients treated at hospitals, up to
10% require amputation of a limb (6). Common sequelae include ankylosis, contracture,
and lymphadema, all the result of massive scaring during the healing process (Figure 3).
The loss of important structures on the face (e.g., the eye), genitalia, and breasts may also
occur as a result of the disease or may be required to treat it successfully. People who
recover from Buruli ulcer are often left with permanent disabilities and unable to care for
themselves. This is particularly devastating for people who live in regions of the world
where life is difficult for even healthy individuals.

4
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Figure 3. Contracture in an arm and leg after healing of Buruli ulcer.
(Adapted from Buruli ulcer: Diagnosis of Mycobacterium ulcerans Disease,
WHO 2001.)
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Treatment

The most effective treatment for Bundi ulcer is surgical excision. Excision of the
early, non-ulcerative stages of the disease is usually curative (76). Because such medical
care is not readily available for many victims of Buruli ulcer, many do not seek medical
care until after the disease has progressed to a large, disfiguring ulcer. For the ulcerative
forms of the disease, surgical excision of the ulcer and a margin of healthy tissue
followed by skin gr�ing is relatively effective; though, some reports indicate that the
disease recurs, requiring further surgery, in more than 15% of cases (76).
Although many drugs such as dapsone, streptomycin, clarithromycin, clofazimine,
and rifampicin are effective against M ulcerans in vitro, none have been found to be
effective in vivo on patients with Buruli ulcer disease (76). Studies which have shown
drugs, such as clofazimine, which are greatly effective in vitro to have no clinical value
for the treatment of Buruli ulcer, suggest that drugs taken systemically may be of no
benefit due to the nature of the lesion, particularly the poor perfusion to it (67, 76). The
anti-convulsant phenytoin, applied topically, has been reported to promote healing of the
ulcerative form of the disease with a reduction in scarring and contractures, but results
have not been substantiated (3).
Several reports have shown treating Buruli ulcer with heat to be a promising
treatment (25, 52). This takes advantage of the fact that M ulcerans is heat sensitive.
However, this method of treatment is not widely utilized and has not been extensively
evaluated. To be effective, the heat must be applied constantly and requires equipment,
such as an electric heating pad or other source with thermostatic control, which is not
readily available in many regions in which Buruli ulcer is endemic. This type of
6

treatment confines patients who are otherwise healthy for long periods of time and is
most likely not suitable for lesions on the face and other body parts.

Geographical Distribution and Epidemiology of Buruli Ulcer

It is believed by many that Buruli ulcer disease was described as early as 1897 by
Sir Albert Cook in his Mengo Hospital Notes which describe the characteristic ulcers
among his patients in Kampala, Uganda (1, 13, 76). Aslop, an Australian surgeon, also
described treating patients with similar ulcers as early as 1937 (5). However, it was not
until 1948 that Mccallum and colleagues described the ulcers in correlation with their
causative agent, which they tentatively named the Baimsdale bacillus after the Baimsdale
region of Australia in which most of their patients with this disease lived ( 48). This
bacterium was later named Mycobacterium ulcerans; however, the disease is still known
as Baimsdale ulcer in Australia (82). Though it bares various monikers in different
regions of the world-for example, Kumusi ulcer in Papua New Guinea, Kasongo ulcer
in Zaire, and Baimsdale ulcer in Australia, the necrotic lesions caused by M ulcerans are
most widely known as Buruli ulcer after the Buruli region of Uganda (2, 11, 3 8). This
region was the site of several large outbreaks of Buruli ulcer in the 1960's and 1970's
which provided the arena for a more thorough investigation and publication of the disease
(11, 16).
In addition to Uganda and Australia, Buruli ulcer has been found endemic to the
Democratic Republic of Congo, Nigeria, Cameroon, Ghana, Papua New Guinea,
Malaysia, French Guiana, Mexico, Bolivia, Sri Lanka, Sumatra, and others totaling over
30 countries (4, 8, 29, 32, 34, 41, 51, 63, 85) (Figure 4). It is interesting to note that
7

Figure 4. Countries in which Buruli ulcer disease has been reported.
Countries shown in black are regions of endemicity. (Adapted from WHO Bunili ulcer
website: http://www.who.int/gtb- buruli/global_situation/index.html.)
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based on the broad distribution of the endemic areas of Buruli ulcer, it has been suggested
that M ulcerans evolved before or during the Jurassic period-before the breakup of the
continents (32). Though Buruli ulcer disease has been found in non-tropical regions
such as southern Australia, Japan, and the People' s Republic of China, it is most
prevalent in tropical regions (20, 33, 79, 80). While the disease has probably always
been most prevalent in the rural communities of equatorial Africa, there seems to have
been a great increase in the occurrence of Buruli ulcer in East Africa in the early 1 970's
and late 1 960's (2, 41). At present, in West Africa a similar epidemic is transpiring,
contributing to the momentously increasing overall incidence of Buruli ulcer disease (4 1 ,
43, 50, 54). Buruli ulcer was recognized as an emerging infectious disease in 1 998 with
the establishment of the Global Buruli Ulcer Initiative by the World Health Organization
(WHO) (85).
Within the many regions and countries of endemicity, Buruli ulcer disease occurs
in well defined areas, often called foci, which can be as small as 2 square kilometers in
size (4 1 , 42, 82). These foci are typically in close proximity to standing or slow moving
water (e.g., a lake, stream, or swampy area) (4 1 , 64). For this reason, it is believed that
the organism is in some way associated with the water or colonizes some organism
associated with the water. While many different organisms have been experimentally
infected with M ulcerans, until recently, the only organisms found to acquire natural M
ulcerans infections were koalas, ringtail possums, and an alpaca (1 9). In 1 999, Portaels,
et al., reported the finding of five water bugs from the families Naucoridae and
Belostomatidae collected in Buruli ulcer-endemic regions of Benin and Ghana to be
PCR-positive for M ulcerans (65). Recently, the aquatic, carnivorous insects of the
9

family Naucoridae were found able to be experimentally infected with M ulcerans as a
carrier and transmit this infection to mice upon biting them (49). The group conducting
these studies was then able to isolate M ulcerans from species of this family of insects
collected from the wild (49). Based on this information, it is likely that insects in the
family Naucoridae do play a role in the transmission of M ulcerans . It is not clear how
important this role is and what other organisms and environmental factors may be
involved in the natural reservoir of M ulcerans.
There have been very few reports of people acquiring Buruli ulcer from those
already infected. The two most common incidences were infection after a human bite
and the infection of a plastic surgeon who had excised a Buruli ulcer lesion
(15, 18). These are considered isolated and possibly unsubstantiated incidences. Buruli
ulcer is not passed from person to person, and infects people of all ages-both male and
female. However, it does occur more often in children (17). There appears to be no link
between the human immunodeficiency virus (HIV) epidemic in Africa and the incidence
of Buruli ulcer disease; and, co-infection with HIV does not appear to alter the course of
an M ulcerans infection (17).

Diagnosis of Buruli Ulcer and Identification of Mycobacterium ulcerans

In regions in which Buruli ulcer is endemic, it is readily diagnosed in the
ulcerative form. A painless ulcer with undermined edges in the absence of the
lymphadenitis, fever, or other inflammation present in infections caused by other bacteria
is unique to the disease caused by M ulcerans. Because the lesions are usually found on
the limbs or trunk, the ones which appear on the face may be mistaken for cancrum oris,
10

or noma, a disease characterized by necrotic facial lesions which unlike M ulcerans
exhibit signs of inflammation (81). Commonly, acid-fast staining is performed on
suspected Buruli ulcers; however, neither the presence nor absence of acid-fast bacilli in
the ulcer can definitively confirm or refute a preliminary diagnosis of Buruli ulcer. In
most cases the organism can be cultured from the lesion, but culturing requires that the
appropriate media and incubation apparatus be available and may take three or more
months (48).
Though generally limited to research and clinical use in industrialized countries,
PCR can be used to definitively identify M ulcerans. The M ulcerans genome contains
two insertion sequences, IS2404 and IS2606, which have not been found together in any
other organism. IS2606 has been found to be present in the genome in up to 40 copies;
while, IS2404 has been found to be present within the genome in over 50 copies (72).
IS2606 has been detected in only one other species-M lentiflavum; while, IS2404 to
date has been detected only in M ulcerans (72). Concurrent detection of both IS2606
and IS2404 in a single isolate is indicative of M ulcerans.

Mycolactone

Due to the presence of only small foci of M ulcerans in even large ulcers it was
suggested as early as 1965 that Buruli ulcer disease was mediated by a diffusible toxin
(12). Several studies have demonstrated that the sterile filtrates of M ulcerans have a
cytopathic effect on L929 murine fibroblasts, causing rounding and detaching from the
monolayer (22, 36, 46). In 1998, George, et al. was able to partially purify the toxin
causing this effect and identify the mechanism by which it functions (22). They
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demonstrated with flow cytometric analysis that the toxin causes cell cycle arrest in the
G0/G 1 phase of the growth cycle accompanied by cytoskeletal rearrangement (22). One
year later, the toxin was completely purified, and its structure was determined to be that
of a 12-membered lactone ring to which two different polyketides were attached (23).
This molecule, designated mycolactone, as a polyketide-derived macrolide is a member
of a class of molecules which are often biologically active. This is the first such
molecule identified' in mycobacteria and any human pathogen. When the biologically
active molecule, designated mycolactone, was subjected to 1 H and 1 3 C NMR, it was
revealed that the compound actually exists as a mixture of two cis/trans isomers in
equilibrium at approximately a 3 :2 ratio (21). The predominant molecule has been
designated mycolactone A (Figure 5). Mycolactone A/B is represented by a single peak
at m/z 765.5 upon mass spectroscopic analysis. It has been found that M ulcerans
produces not just two isomers of mycolactone, but multiple heterogeneous congeners
which primarily differ in their number of double bonds and hydroxyl groups (9). In
2003, Mve-Obiang, et al. reported that while mycolactone A/B was originally isolated
from M ulcerans 1615, a Malaysian isolate; it has been found in all cytotoxic strains of
M ulcerans tested except two isolates from Mexico (56). They further reported that a
mycolactone C, represented by a peak at mlz 726.3 upon mass spectroscopic analysis,
was the predominant mycolactone in eight Australian strains analyzed; while, a
mycolactone D (m/z 781.2) was present in two Asian strains of M ulcerans (56).
Though the congeners have the same biological activity, they differ in potency (56). The
fact that strains of M ulcerans of the same geographic region appear to produce the same
repertoire of mycolactones may explain the variation in presentation and severity of
12
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Figure 5. Structure of 1) mycolactone A and 2) mycolactone B.
(Adapted from Gunawardana, et al., 1999.)
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Buruli ulcer among these different regions.
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II. Materials and Methods
Bacterial Culture

Mycobacterium ulcerans 1615, originally isolated from a human patient in
Malaysia, is a part of the Trudeau Mycobacterial Culture Collection {TMC) and was
obtained from the American Type Culture Collection (ATCC 35840) (Manassas,
Virginia). Mycolactone-negative mutants of M ulcerans 1615 not constructed as a part
of this work, mutants 97 and 115, were obtained from Dr. Armand Mve-Obiang and were
constructed by him via transposon mutagenesis via a phage delivery system while
working at the University of Tennessee in Knoxville. All M ulcerans cultures were
grown in stir flasks at 32t in Middlebrook 7H9 broth (M7H9) (Difeo, Detroit, Michigan)
with 10% oleic acid-albumin-dextrose-complex (OADC) unless otherwise stated. OADC
was prepared with bovine serum albumin (BSA) from Sigma (Saint Louis, Missouri) and
all other reagents from Fisher Scientific (Pittsburgh, Pennsylvania). Both Reid's
synthetic medium and Sauton's synthetic medium were prepared as described in The
Mycobacteria: A Sourcebook Part A using reagents purchased from Fisher Scientific
(84 ). The M fortuitum strain used, M fortuitum fortuitum da Costa Cruz, is a Spanish
isolate and was obtained from ATCC (ATCC 6841) and is a part of the TMC. It was
grown in M7H9 with 10% OADC (M7H9 + OADC) while shaking at 37C.

Transposon Mutagenesis

Transposon mutagenesis was performed using the commercially available
TM

EZ::TN <KAN-2>Tnp TransposomeTM Kit from Epicentre (Madison, Wisconsin). The
15

transposome is constructed by mixing the transposon, a segment of linear DNA
containing the kanamycin resistance gene Tn903 flanked by 19 bp transposase
recognition sequences, and the transposase in the absence of magnesium (Figure 6). This
transposome construct was introduced into M ulcerans through electroporation as
described below. Upon entry into the cell, the transposome complex is activated by Mg2+
present in the cell, and the transposon randomly inserts into the genomic DNA of the
host. Insertion mutants were selected on Middlebrook 7HlO agar (Difeo) supplemented
with 10% OADC (M7Hl0 + OADC) with kanamycin at a concentration of 30 µg/mL,
because the transposon includes the Tn903 selectable marker, conveying kanamycin
resistance (Figure 7).

Electroporation of M. ulcerans

Electrocompetent cells were prepared in the following manner. All steps were
carried out in and all reagents were used at room temperature unless otherwise stated.
Log-phase cultures were harvested by centrifugation at 5,509 x g for 10 min without
brake. The supernatant was carefully discarded, and the pellet was gradually resuspended
in a volume of 10% glycerol (Fischer Scientific) equal to one half the volume of the
original cultur_e. The cells were centrifuged as above, and the pellet was gradually
resuspended in a volume of 10% glycerol equal to one fifth the volume of the original
culture. The cells were again centrifuged as above, and the supernatant was carefully
discarded. The cells were finally resuspended in a volume of 10% glycerol equal to one
one thousandth the volume of the original culture. The cells were then aliquoted in 60 µL
volumes into sterile 1.5 mL microcentrifuge tubes. Because mycobacteria have
16
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extremely low transformation efficiencies when compared to other bacteria and
transformation efficiencies of competent cells decrease after storage, electrocompetent
cells were used immediately.
Immediately before electroporation, the 60 µL volume of electrocompetent cells
was loaded into a BT:x® 2 mm gap cuvette (Fisher Scientific) along with 1 µL of DNA
(at a concentration of 1 µg/µL unless otherwise stated). The cuvette was placed in the
electroporation ch�ber and pulsed with a Bio-Rad Gene Pulser® II with the following
parameters: 2.5 kV voltage, 25 µF capacitance, and 800 n resistance. Immediately after
electroporation, the content of the cuvette was transferred to 2 mL of warm M7H9 +
OADC, unless otherwise stated, and placed at 32t in a rollerdrum for 72 hours. The
cells were then plated on M7H1 0 + OADC plates, unless otherwise stated, with the
appropriate antibiotic added. The plates were double wrapped in Parafilm M® (Pechiney
Plastic Packaging, Chicago, Illinois) to prevent dehydration and incubated at 32t. Plates
were checked weekly.

Electroporation of M. fortuitum

Electrocompetent cells were harvested, washed, aliquoted, and electroporated as
described for M ulcerans. Immediately after electroporation, cells were transferred to 2
mL M7H9 + OADC and shaken at 37t for 5 hours before being plated on M7H10 +
OADC with 30 µg/mL aparamycin. Plates were incubated at 37C and checked daily.
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To confirm the presence of a transposon insertion in kanamycin resistant colonies
after transposon mutagenesis, a 1, 108 bp fragment of the transposon was amplified with
primers Tnpl (5'-CTC AAA ATC TCT OAT OTT ACA TTG C-3' ) and Tnp2 (5'-GGT
TOA TOA GAG CTI TOT TOT AGO T-3' ). To confirm the presence of M ulcerans, a
492 bp fragment of 1S2404, an insertion element unique to M ulcerans, was amplified as
described by T. Stinear, et al. with primers MU5 (5' -AOC GAC CCC AGT GOA TTG
GT-3') and MU6 (5'-CGG TOA TCA AOC OTT CAC GA-3') (72). A small portion of
each colony to be tested was placed in 200 µL of sterile water and boiled for 20 minutes.
The bacterial cells were removed by centrifugation. Each 50 µL reaction contained 10
µL of the boil as template, 250 pmol of each primer, 2.5 units of enzyme mix from the
™

™

FailSafe PCR Kit (Epicentre), and 25 µL of 2 x FailSafe PCR enzyme Buffer B which
contains dNTPs. As positive controls for the presense of the transposon or 1S2404, a
reaction was prepared with a template of either 1 ng of the transposome in 10 µL of
sterile water or 200 ng of M ulcerans genomic DNA 10 µL of sterile water, respectively.
For the detection of M ulcerans associated with snails, 10 µL of total genomic DNA
isolated from snail tissue was used as template. The reactions were carried out in a
thermocycler (Eppendorf, Hamburg, Germany) with an initial denaturation period of 5
minutes at 94t followed by 30 cycles of 1 ) 94t for 1 minute, 2) 55t for 1 .5 minutes, and
3) 72t for 1 .5 minutes followed by a final elongation period of 10 minutes at 72t.
To obtain the sequences of the genomic DNA flanking the transposon of M
ulcerans 1615 :tnp6w (i.e., to determine which gene was interrupted to give the
mycolactone-negative phenotype), an arbitrarily primed PCR method was performed.
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The protocol was obtained from Dr. Eric Rubin at Harvard School of Public Health
(Boston, Massachusetts) in whose lab the protocol had been adapted from an original
protocol by O'Toole (59). A separate first round PCR reaction was prepared for each
side of the transposon. For this reaction, 50 µL reactions were prepared with 1 µL
mutant 1615:tnp6w genomic DNA as template, 1 unit of Taq DNA polymerase, 1 mM
dNTPs, 1.5 mM MgCh, 1 mM of ARBl random primer (5'-GGC CAC GCG TCG ACT
AGT NNN NNN NNN GAG GG-3'), and 1 mM of either ARBl TNPl (5'-GCG GCT
TTG TTG AAT AAA TCG A-3') to amplify genomic DNA downstream of the
transposon or ARB1TNP2 (5'-TCC ATG TTG GAA TTT AAT CGC G-3') to amplify
genomic DNA upstream of the transposon. Both ARB1TNP 1 and ARB 1TNP2 are
complementary to regions on either side of the transposon approximately 150 bp within
the transposon. The reactions were carried out in a thermocycler with an initial
denaturation period of 3 minutes at 95t followed by 10 cycles of 1) 95t for 30 seconds,
2) 35t for 30 seconds, and 3) 72t for 1.5 minutes followed by an additional 30 cycles of
1) 95t for 30 seconds, 2) 50t for 30 seconds, and 3) 72t for 2 minutes plus 5 seconds
per cycle followed by a final elongation period of 7 minutes at 72t.
For the second round of the arbitrary primed PCR protocol, 50 µL reactions were
prepared using 1 µL of the first round products as template, 1 unit of Taq DNA
polymerase, 1 mM dNTPs, 1.5 mM MgCh, 1 mM of ARB2 arbitrary primer (5 '-GGC
CAC GCG TCG ACT AGT AC-3') and 1 mM of either ARB2TNP1 (5' -AGT TGA
AGG ATC AGA TCA CGC-3') or ARB2TNP2 (5'-TTC CCG TTG AAT ATG GCT
CAT AAC-3 '). Both ARB2TNP1 and ARB2TNP2 are complementary to regions on
either side of the transposon between the first round primers complementary to the
20

transposon (ARB 1TNP 1 and ARB 1TNP2) and the primers to be used for sequencing.
The reactions were carried out in a thermocycler with an initial denaturation period of 3
minutes at 95t followed by 30 cycles of 1) 95t for 30 seconds, 2) 62t for 30 seconds,
and 3) 72t for 1 minute plus 5 seconds per cycle followed by a final elongation period of
7 minutes at 72t. The products were sequenced using the sequencing primers included
TM

in the EZ::TN <KAN-2>Tnp Transposome™ Kit by the University of Tennessee
Molecular Biology Sequencing Facility (Knoxville, Tennessee).
To confirm transformation with pPR27HI and pPRFURA, an 822 bp fragment of
the hygromycin phosphotransferase gene (hph) which conveys hygromycin resistance
was amplified using the primers HPHl (5'-CGA TGT AGG AGG GCG TGG ATA-3')
and HPH2 (5'-GCT TCT GCG GGC GAT TTG TGT-3'). To confirm transformation
with pYUBl78, a 476 bp fragment of the aparamycin resistance gene (aac(3)-1Va)
contained on it was amplified using the primers APRAl (5'-GTC CAC AGC TCC TTC
CGT AGC-3') and APRA2 (5'-CTC GAG ATA ATC GAC GCG TAC C-3'). A small
portion of each colony to be tested was placed in 200 µL of sterile water and boiled for
20 minutes. The bacterial cells were removed by centrifugation. Each 50 µL reaction
contained 10 µL of the boil as template, lmM of each primer, 1 unit of Taq DNA
polymerase, 1 mM dNTPs, and 1.5 mM MgCh. For positive controls, a reaction was
prepared with a template of 100 ng of the respective plasmid in 10 µL of sterile water.
The reactions were carried out in a thermocycler with an initial denaturation period of 5
minutes at 94t followed by 30 cycles of 1) 94t for 1 minute, 2) 55t for 1 minute, and 3)
72t for 1 minutes followed by a final elongation period of 10 minutes at 72t.
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Cytopathicity Assay

L929 murine fibroblast cells were obtained from ATCC (ATCC CCL I ) and were
maintained by passaging in Dulbecco modified Eagle medium (DMEM) supplemented
with 5% heat-inactivated calf serum (Gibco BRL, Grand Island, New York) at 37t with
5% carbon dioxide. To initially determine if the six insertion mutants obtained via
transposon mutagenesis were cytopathic, a qualitative cytopathicity assay was performed.
For this assay, the cells were plated at 6

x

104 cells/well (after dilution to 6

x

1 04

cells/mL using a hemocytometer) in a 24-well tissue culture plate and allowed to form a
confluent monolayer for 24 hours. At this time, 50 µL of sterile filtrate of each of the
mutants was added to a well. Sterile filtrate was obtained by passing 1 mL of culture
through a Steritop™ 0.22 µm pore filter (Millipore, Billerica, Massachusetts). After 24
and 48 hours, the cells in each well were observed for rounding and detachment, which
both indicate cytopathicity.

Mass Spectroscopy
All mass spectroscopy (MS) analysis was performed by Dr. Richard E. Lee of the

College of Pharmacy, Department of Pharmaceutical Sciences, University of Tennessee
Health Science Center (Memphis, Tennessee).

Isolation of ASLs

Acetone soluble lipids (ASLs) were extracted as described by George, et al. (22).
The cells of 250 mL of bacterial culture were harvested by centrifugation at 5,509

x

g for

10 min at room temperature without brake as described above for harvesting cells for
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electroporation. Most of the supernatant was discarded; while, a small amount was used
to resuspend the pellet for transferring the cells to a preweighed 30 mL glass Corex® tube
(Fisher Scientific). The cells were then centrifuged at 4,000 x g for 10 min at room
temperature (Fisher MarathonTM 21 OOOR benchtop centrifuge; Fisher Scientific). The
supernatant was discarded, and the pellet was dispersed around the walls of the tube with
a small spatula for faster drying in a vacuum oven (Fisher IsotempTM vacuum oven model
280A; Fisher Scientific) at approximately 55t and approximately -15 in.Hg. It took 8-10
hours for the pellets to dry completely. During this process, the tube was wrapped in foil
to prevent excess light exposure. For quantitative purposes, the dried cell matter was
massed (analytical balance model TR-204; Denver Instrument Company, Denver,
Colorado). Then, 15 mL of chloroform:methanol (2: 1, vol/vol) (Fisher Scientific) was
added to the pellet and stirred for 2 hours. After this time, the tube was centrifuged at
4,000 x g at 4t for 15 min to separate the organic layer from the cell debris. Organic
layer (top layer) was carefully removed by Pasteur pipette to a vial for evaporation under
™

nitrogen using a heating module (Pierce Reacti-Therm heating module; Rockford,
Illinois) at approximately 55t. After the chloroform:methanol solvent was completely
evaporated, the vial was placed on ice; and, 2 mL of ice-cold acetone was added to
resuspend the ASLs present in the isolated organic fraction (total lipid content of cells).
This suspension was then transferred to a small pre-weighed vial, and the acetone was
evaporated off as described for the chloroform:methanol. For quantitative purposes, the
dry ASLs were massed (Metler Toledo AT20 balance;Metler Toledo, Columbus, Ohio).
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Analysis of ASLs by TLC

ASL analysis was performed by thin-layer chromatography (TLC) using silica
coated aluminum TLC plates (Alltech, Deerfield, Illinois) and a solvent system consisting
of chloroform:methanol:water (90: 10: 1, vol:vol:vol) (Fisher Scientific). After the TLC
plate was run, it was dried with hot air from a common hair dryer. The TLC plate was
visualized under ultraviolet light, and all visible bands were noted. For further
1

visualization of the ASLs, the TLC plate was developed by dipping in a para
anisaldehyde stain solution, then drying with hot air. The stain was prepared by
combining the following reagents in the following order: 6 mL glacial acetic acid
(Mallinckrodt Balcer, Inc., Phillipsburg, New Jersey), 30 mL para-anisaldehyde (Acros
Organics, a division of Fisher Scientific), 540 mL ice-cold ethanol (Aaper Alcohol And
Chemical Company, Shelbyville, Kentucky), and 30 mL concentrated sulfuric acid
(Mallinckrodt Balcer, Inc.).

Isolation of M. ulcerans Genomic DNA

The isolation of genomic DNA from M ulcerans is very difficult due to its
polyketide-enriched cell wall. There is no published reference for a consistently high
yielding genomic DNA isolation protocol for M ulcerans. The technique used in this
work was adapted from protocols used to isolate genomic DNA from M tuberculosis and
other mycobacteria. The cells of 100 mL of log-phase culture were harvested by
centrifugation at 7,500 x g for 15 min without bralce. The supernatant was decanted; and,
the pellet was resuspended in 5 mL TE (pH 8.0) (Fisher Scientific) and transferred to a 50
™

™

ml Nalgene Oalc Ridge Teflon FEP tube (Fisher Scientific). To assist in cell lysis, 0.5
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mL of a 10 mg/mL solution of lysozyme (Sigma) was then added, and the cells were
incubated at 37t for 1 hour. To further lyse cells, 30 µL of 10% SDS (Fisher Scientific)
and 700 µL of 20 mg/mL proteinase K (Sigma) were added and incubated at 65C
overnight. Proteinase K was heat-inactivated at 80C for 10 min, and the cell mixture was
cooled to room temperature before 30 µL of 4 mg/mL RNaseA (Sigma) was added and
the mixture incubated at 37C for 45 min. 1 mL of SM NaCl and 800 µL of 10%
CTAB/0.7M NaCl (Fisher Scientific) was added to the mixture which was then incubated
at 65" C for 20 min. The mixture was then cooled to room temperature before the
genomic DNA was extracted. Genomic DNA was extracted by adding 8 mL
chloroform:isoamyl alcohol (24:1, vol:vol) (Fisher Scientific) and vigorously shaking for
30 seconds. After phase separation was apparent, the tube was centrifuged at 23,500 x g
for 20 min at 4C. The aqueous layer was removed and genomic DNA was extracted a
second time in an identical manner using 8 mL phenol: chloroform: isoamyl alcohol
(25:24:1, vol:vol:vol) (Sigma). The genomic DNA was then precipitated with 800 µL
3M sodium acetate (pH 5.2) (Fisher Scientific) and 8 mL isopropanol (Sigma) and
centrifugation at 23,500 x g for 20 min at 4C. The DNA was washed twice with 8 mL
70% ice-cold ethanol then allowed to dry. It was resuspended in 0.5 mL water at 65C for
30 min then overnight at 4C. The DNA was quantitated and analyzed for purity via
spectrophotometry (Eppendorf Biophotometer; Eppendorf).

Southern Blot

Approximately 2 µg of genomic DNA of mutant 1615:tnp6w was digested
overnight at 37C in each of three digestions with Sacl, Pvull, and EcoRI (New England
25

Biolabs, Beverly, Massachusetts). Genomic DNA from M ulcerans 1615 and an
™

Escherichia coli strain known to have an insertion of the EZ::TN <KAN-2>Tnp
transposon were also digested with EcoRI to be used as a negative and positive control,
respectively. All digestions along with Hindlll cut A DNA ladder (Promega) and 1 kb
DNA ladder (Promega) were electrophoresed using a .8% agarose gel prepared with
ethidium bromide. After electrophoresis, the gel was photographed using UV
illumination to aid in interpretation of the blot.
The gel was prepared for the Southern blot as prescribed by the ECL Direct
TM

Nucleic Acid Labelling and Detection Systems kit (Amhersham Pharmacia Biotech, Inc.,
Piscataway, New Jersey). Briefly, the gel was subjected to depurination by agitation for
10 minutes in a depurination solution of 250 mM HCl (Fisher Scientific). After rinsing
with distilled water, the gel was subjected to denaturation by agitation for 25 minutes in a
denaturation solution of 1.5 M NaCl and 0.5 M NaOH (Fisher Scientific). After rinsing
with distilled water, the gel was subjected to neutralization by agitation for 30 minutes in
a neutralization solution of 1.5 M NaCl and 0.5 M Tris HCL (Fisher Scientific) at pH 7.5.
After the initial 30 minute period, the neutralization solution was replaced with fresh
solution and the gel was agitated in this solution for an additional 15 minutes. The
capillary blot was constructed in the traditional manner as prescribed by the ECL Direct
TM

Nucleic Acid Labelling and Detection Systems kit using 20 x SSC (0.3 M Na3 citrate and
3 M NaCl at pH 7.0 (Fisher Scientific)) as the transfer buffer, Whatman 3 MM paper
(Whatman, Inc., Clifton, New Jersey) as a wick, and a Hybond-N+ membrane
(Amersham).
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After overnight blotting, the blot was removed, rinsed with 6

x

SSC, allowed to

air dry, and baked at 80t for 2 hours. The blot was pre-hybridized for 1 hour at 42t and
then hybridized with labeled probe under the same conditions overnight. The probe was
prepared from 100 ng of a 1,108 bp fragment of the transposon amplified with primers
Tnpl (5'-CTC AAA ATC TCT GAT GTT ACA TTG C-3') and Tnp2 (5'-GGT TGA
TGA GAG CTI TGT TGT AGG T-3'). The probe was labeled as directed with a
proprietary labeling reagent followed by a glutaraldehyde solution both included in the
ECL ™ Direct Nucleic Acid Labelling and Detection Systems kit. After hybridization, the
blot was washed twice for 20 minutes each time at 42t with primary wash buffer (6 M
urea, 0.4% SOS, and 0.5

x

SSC (Fisher Scientific)). It was then washed twice for 5

minutes each time at room temperature in secondary wash buffer (2 x SSC). The blot
was drained of secondary wash buffer before being developed for 1 minute with equal
parts of detection reagents 1 and detection reagents 2 included in the kit. The blot was
drained, wrapped in plastic film, and placed in a film cassette. The film was exposed for
several minutes.

Cultivation of Snails

Schistosome-infected and uninfected snails of the species Biomphalaria glabrata
were obtained from Dr. Fred Lewis, Schistosomiasis Laboratory, Biomedical Research
Institute (BRI) (Rockville, Maryland). Those which were infected had been exposed to
the miracidiae of Schistosoma mansoni strain NMRI, a Puerto Rican strain, en masse at
eight miracidiae per snail.
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The snails were maintained as instructed by Dr. Lewis in shallow translucent
plastic containers (12 in x 7 in x 4 in) with non-airtight lids made of the same material.
The containers were filled to a depth of two inches with water (1.5 L) which had been
filtered using a commercially available water filtration system (Pur® Select Faucet
Mounted Filtration System; Pur, available at most major retail stores) and then aerated for
two to three days before use. Such conditioning of the water is necessary to insure that
the snails do not come in contact with substances such as chlorine and copper which are
deadly to them. Cercariae release greatly decreases the lifespan of the schistosome
infected snail. Because a change in light intensity and temperature are stimuli which
cause cercariae release, snails were maintained at room temperature and in constant light.
The snails of each container were fed a single segment of carefully washed Romaine
lettuce with an area of approximately two square inches every day. Any uneaten food
was removed the following day. The snails were placed in common glass 500 mL
beakers filled with conditioned water every third day for the snail containers to be
disinfected, washed, and refilled with conditioned water. Once weekly, groups of snails
were fed approximately .5 in2 of a snail food supplement.

Prepared Snail Food Supplement

The snail food supplement was prepared as follows: 250 mL of water was stirred
and heated. To this was added 2.5 g wheat germ (ICN Biomedicals, Inc., Aurora, Ohio),
1.25 g nonfat dried milk (Carnation®, available at most major retail stores), 2.5 g Ward's
Cereal Grass Media (Ward's, Saint Catharines, Ontario, Canada), 2.5 g fish flakes (Tetra,
Blacksburg, Virginia), and 2.5 g sodium alginate (Fisher Scientific). After mixing, the
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mixture was poured into a glass pan and autoclaved for 20 minutes, then cooled
overnight. After cooling, 2% CaCh was poured on the surface and allowed to sit for 24
hours. The CaCh was poured off and replaced with sterile water. The supplement was
stored at 4t.

Infection of Snails with M. ulcerans

A group of 6 uninfected snails were placed in a 50 mL conical tube with 25 mL of
conditioned water to which 2.5 mL of M ulcerans 1615 culture was added. A control
group of 6 snails was placed in a 50 mL conical tube to which 2.5 mL of sterile M7H9 +
OADC was added. After 24 hours, all snails had died. They were washed repeatedly
with sterile water. Each group was then placed in 25 mL of a 10 µg/mL solution of
amikacin, an antibiotic used to kill extracellular M ulcerans during phagocytosis assays.
After 36 hours, the snails were rinsed with sterile water, frozen at -80t, and ground over
dry-ice in a sterile tissue grinder. Approximately 20 mg of tissue was placed in a
microcentrifuge tube for total genomic DNA extraction. The remaining tissue was
decontaminated and plated as described below.

Isolation of Total DNA from Snail Tissue

The Wizard® Genomic DNA Purification Kit (Promega, Madison, Wisconsin)
was used to isolate total DNA from 20 mg samples of ground snail tissue. The protocol
was modified to include boiling at 1OOt for 20 minutes after the addition of the Nuclei
Lysis Solution. After which, the sample was allowed to cool to room temperature before
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continuing with the protocol provided in the kit. All reagents used were included in the
kit.
Environmental Infection of Schistosome-Infected Snails with M. ulcerans

Two groups of 10 schistosome-infected snails each were maintained for 4 weeks
to allow time for the schistosome infection to develop. 2 mL of M ulcerans 1 6 1 5 culture
was washed twice by centrifugation (4,000 rpm, 25t, 10 min) and resuspension in sterile
water to reduce its quantity of mycolactone and remove elements of the M7H9 + OADC
medium in which it was grown which would be harmful to the snails. The final pellet
was resuspended in 2 mL of sterile water and added to a 500 mL beaker containing 250
mL conditioned water and one group of 10 snails. The other group of 10 snails served as
a control and was held in a 500 mL beaker containing 252 mL conditioned water. Both
beakers were covered in plastic wrap. After 24 hours, each group of snails was returned
to its respective container and maintained as usual for 8 weeks.

Infection of Schistosome-Infected Snails with M. ulcerans through Foodborne
Inoculation

Two groups of 10 schistosome-infected snails each were maintained for 4 weeks
to allow time for the schistosome infection to develop. 2 mL of M ulcerans 1 6 1 5 culture
was washed twice by centrifugation and resuspension in sterile water as described for the
environmental infection of snails. The final pellet was resuspended in a very small
volume of water (100 µL) and was injected into 1 g of the prepared snail food
supplement. This food source is very dense and provided a good matrix for delivery of
the bacteria to one group of 1 0 snails held in a 500 mL beaker containing 250 mL
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conditioned water. 1 g of sterile food supplement was given to the control group of 10
snails held in another 500 mL beaker containing 250 mL conditioned water. Both
beakers were covered with plastic wrap. After 24 hours, each group of snails was
returned to their respective containers and maintained as usual for 8 weeks.

Preservation of Snails

Snails of both the environmental and food infection studies were checked daily.
When dead snails were not cannibalized, they were washed with sterile water before
being frozen to be decontaminated and plated later or before being removed from their
shells using sterile forceps to be fixed. Snail tissue for slide preparation was preserved by
immediate emersion in Bouin's fixative (LabChem, Inc., Pittsburgh, Pennsylvania) for 4
days. The snail was then removed and immersed in the following solutions for 24 hours
each: sterile water, 10% ethanol, 20% ethanol, 30% ethanol, 50% ethanol, and 70%
ethanol.

Preparation of Slides

Histological sectioning and preparation of slides was performed by Histo-Path of
America (Millersville, Maryland). Sections were stained alternately by hematoxylin-and
eosin and acid-fast staining. These two staining procedures were chosen, because
hematoxylin-and-eosin staining is the procedure commonly used to stain snail sections;
while, acid-fast staining is the most commonly used staining procedure for identifying
mycobacteria. There are several references which are helpful in orienting yourself while
viewing histological snail sections stained with hematoxylin and eosin.
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Plating Snail Tissue

Before plating, snrul tissue was frozen at -80t and ground over dry-ice using a
sterile tissue grinder. The decontamination protocols used were adapted from procedures
used to decontaminate mammalian tissue for the isolation of M ulcerans. For the
decontamination of snails from the preliminary infection, most homogenates had volumes
of 100-200 µL. To this sample, .5 mL 2 M HCl was added. The sample was vortexed
and incubated at room temperature for 15 minutes. The tubes were then centrifuged at
6,000

x

g for 15 min and the supernatant decanted. Attempts to neutralize the pellet were

made by adding 2% NaOH drop-by-drop while monitoring the pH with pH test strips.
Because this was not a very effective method, a new method was adapted for the
subsequent infection studies. For the infection of snails with M ulcerans through 1)
environmental inoculation and 2) foodborne infection, the ground snail tissue along with
5 mL of sterile water used to wash out the tissue grinder was placed in a 50 mL conical
tube. To the 5mL volume, an equal volume of 2% NaOH was added. The sample was
vortexed and incubated at room temperature for 15 minutes. After 15 minutes, the
samples were centrifuged at 3,000

x

g for 1 5 min to collect debris and bacteria as a pellet.

After centrifugation, the supernatant was decanted and the sediment was resuspended in 1
mL of sterile water. 1 drop of a 0.4% phenol red powder in 2% NaOH was added to the
solution. The sample was neutralized using a 2 N HCl solution added drop-by-drop. The
phenol red indicator allowed visual estimation of neutralization. 100 µL, 50 µL, and the
remaining sample concentrated to 100 µL were plated on M7H9 + 50 µg/mL
cycloheximide. Plates were wrapped in parafilm and incubated at 32t for 4 months.
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III. The Identification of a Mycolactone-Negative Mutant of
Mycobacterium ulcerans

Introduction

Mycobacterium ulcerans causes the third most common mycobacterial infection
in immunocompetent humans world-wide. This infection causes a condition commonly
referred to as Buruli ulcer disease, which is characterized by necrotizing skin lesions.
Buruli ulcer disease is considered by many to be the most important mycobacterial
infection in West Africa and possibly other parts of the world. Poor health care
availability and substandard infrastructures in the regions endemic to M ulcerans
infection make it difficult to determine the true number of people affected by this disease
or even how the disease is transmitted. At present, the only effective means of combating
this disease is surgical excision followed by skin grafting, measures which are not readily
available in endemic regions. Any knowledge that could lead to an effective treatment or
to the prevention of transmission is greatly needed.
In 1999, a toxin produced by M ulcerans was isolated and its structure was
determined to be that of a 1 2-membered lactone ring to which two polyketide chains are
attached. This molecule was designated mycolactone and was shown upon injection into
Guinea pigs to produce ulcers that are nearly identical to those produced by the injection
of M ulcerans itself (23). This and the absence of ulcer formation in Guinea pigs upon
injection with a spontaneous mycolactone-free mutant of M ulcerans suggests that
mycolactone could be solely responsible for the development of Buruli ulcer disease (23).
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It has been suggested that an antitoxin targeted against mycolactone could be an effective
treatment for Buruli ulcer disease (78).
However, the development of an antitoxin or other treatment for Buruli ulcer is
not the principal motivation for studying mycolactone. As a polyketide-derived
macrolide, mycolactone is a member of a class of compounds which are often
biologically active and pharmaceutically useful (e.g., the antifungal amphotericin B, the
immunosuppressant rapamycin, the antihypercholesterolemic lovastatin, etc.). Some
polyketides have even multiple pharmacological activities (44). The polyketide
antibiotic erythromycin is also a gastrointestinal stimulant; and, the immunosuppressant
FK506 is also an antifungal (39, 45). Mycolactone itself has been demonstrated to be
biologically active in that in an animal model it causes cell death and lack of an acute
inflammatory response, mimicking the appearance of Buruli ulcer (24). Mycolactone
has also been demonstrated to cause arrest of the cell cycle in the Go/01 phase in both
L929 murine fibroblasts and 1774 murine macrophages (23, 24). Based on these
properties, it is plausible that mycolactone could be of some pharmaceutical value as an
antineoplastic agent, antibiotic, immunosuppressant or other drug either as it occurs in
culture or in a modified state.
Further studies will be required for either the development of an antitoxin or the
evaluation of mycolactone as a biologically active compound. Research aimed at these
and any other findings with regard to mycolactone would be greatly facilitated by the
ability to produce mycolactone in a fast growing mycobacterium (e.g., M smegmatis or
M fortuitum). For these reasons, the identification of the molecular machinery required
to produce this mycolactone is imperative. Based on structural analysis, it was
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hypothesized that the biosynthesis of mycolactone requires at least 1 00 kb of DNA
comprising two polyketide synthase (PKS) genes, an acyl transferase, and a p450
hydroxylase. The large size of the biosynthetic pathway for mycolactone precluded
ready cloning but made transposon mutagenesis a possible strategy for identifying these
genes.
The purpose of the following experiments was to create a mycolactone-negative
mutant of M ulcerans through transposon mutagenesis and characterize this mutant with
the intention of identifying a gene involved in mycolactone production. At the time of
this study, no defined mutant of M ulcerans had been created, and there was no
established method for making such mutants.

Results

In an effort to identify genes responsible for the production of mycolactone,
efforts to produce a mycolactone-negative mutant of M ulcerans via transposon
mutagenesis were undertaken. Many attempts to create insertion mutants of M ulcerans
™

'™

using the EZ::TN <KAN-2>Tnp Transposome Kit from Epicentre were made by
delivering the transposon via electroporation. Electrocompetent cells were prepared by
washing log-phase cultures (grown in stir flasks at 32t in Middlebrook 7H9 with 1 0%
oleic acid-albumin-dextrose-complex (M7H9 + OADC)) with successively smaller
volumes of ice-cold 1 0% glycerol and apportioning the final volume of cells into 60 µL
aliquots. Each aliquot of cells was electroporated with 1 µL (20 ng/µL) of the
transposome in a 2 mm gap cuvette with a pulse of parameters 2.5 kV, 25 µF, and 800 n.
The cells were immediately transferred to M7H9 + 0ADC and incubated in a rollerdrum
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for 72 hours; after which, the cells were plated on selective media--M7H9 + OADC with
10 µg/µL kanamycin-and incubated at 32C. After eight weeks of incubation, eight
colonies had appeared on various selective plates. Five of these colonies were verified
via PCR to contain the Tn903 kanamycin resistance gene contained on the transposon
(Figure 8).
One of these five colonies (mutant 1615:tnp6w), unlike wild-type M ulcerans
which is yellow, remained white after several months incubation. Because it was known
that mycolactone imparts the yellow color to wild-type M ulcerans and spontaneously
arising mycolactone deficient mutants of M ulcerans are white, it was suspected that this
white colony was mycolactone-negative. Having the same morphology and growth rate
as wild-type M ulcerans, it was unlikely that any of the colonies were not M ulcerans;
however, to verify their identity as such, mutants 1615:tnp6w and 1615:tnp3, an insertion
mutant with a wild-type phenotype, were subjected to PCR analysis for the presence of
the insertion element 1S2404 unique to M ulcerans. Both mutants were PCR-positive for
the presence of 1S2404, confirming them to be M ulcerans (Figure 9).
Both mutants 1615:tnp6w and 1615:tnp3, which was used as transposon
containing, phenotypical normal control, were inoculated into M7H9 + OADC for
expansion. ASLs were isolated from log-phase cultures via methanol:chloroform
extraction as described by George, et al. (22). Both are PCR-positive for the presence of
insertion element 1S2404 unique to M ulcerans.
ASLs of 1615 :tnp6w were analyzed for the presence of mycolactone via thin
layer chromatography (TLC) on silica-coated aluminum plates. The ASLs of both M
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Figure 8. Mutants 1615:tnpl and 1615:tnp3-6 are PCR-positive for the EZ: :TNrM
<KAN-2> Top Transposome™.
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mutants 1615:tnp6w and 16 15:tnp3 for the presence of 1S2404.
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ulcerans 1 6 1 5 and mutant 1 6 1 5 :tnp3 were included as controls. Approximately equal
volumes (approximately 1 6 µL) and masses (approximately 825 µg) of AS Ls were
loaded on the plate for each of the three samples, and the TLC was run in a
chloroform:methanol:water (90: 1 0: 1, vol:vol:vol) solvent before being stained with para
anisaldehyde staining solution. While mycolactone was present in both the ASLs
isolated from M ulcerans 1 6 1 5 and the mutant 1 61 5 :tnp3 as a band with a ratio to front
(Rr) value of approximately 0.23, mycolactone was not present in the ASLs of mutant
1 6 1 5 :tnp6w (Figure 1 0). On an additional TLC analysis (not shown) for which nearly
twice the mass of ASLs was loaded (more than 1 .5 mg), there was still no mycolactone
detected in the AS Ls isolated from mutant 1 6 1 5 :6w.
To further characterize the 1 6 1 5 :tnp6w mutant, a cytopathicity assay was
performed on sterile filtrate of the mutant. Sterile filtrate was obtained by passing 1 mL
of log-phase culture through a .22 µm pore polyethersulfone filter. 50 µL of the sterile
filtrate was added to a well of a 24-well tissue culture plate containing a confluent
mono layer of L292 murine fibroblasts plated at 6

x

1 04 cells/well. The sterile filtrates of

wild-type M ulcerans 1 6 1 5 and mutant 161 5 :tnp3 as well as sterile M7H9 + OADC were
used as controls. At 24 and 48 hours, the cells were examined for rounding and
detachment, which are both indicative of cytopathicity. At 48 hours, as expected, unlike
those exposed to sterile M7H9 + OADC, which remained a healthy confluent monolayer
of rhomboid shaped cells (Figure 1 1 ), the cells exposed to the sterile filtrate of wild-type
M ulcerans 1 6 1 5 exhibited a great degree of rounding and detachment (Figure 12).
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Figure 10. TLC analysis of ASLs isolated from M. ulcerans mutant
1615:tnp6w.
While mycolactone is present as a band with an Rr value of approximately .23 in
the ASLs of M ulcerans 1 6 1 5 and M ulcerans mutant 1 6 1 5 :tnp3, mycolactone is
not present in the ASLs of M ulcerans 1615 :tnp6w.
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Figure 11. L929 murine fibroblasts after exposure to M7H9 + OADC.
Picture was taken at 48 hours and 100 x magnification. Cells are phenotypically
undisturbed.

Figure 12. L929 murine fibroblasts after exposure to sterile filtrate of M. ulcerans
1615.
Picture was taken at 48 hours and 100 x magnification.
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The sterile filtrate of the mutant 1615 :tnp6w had no apparent cytopathic effect. After 48
hours, fibroblasts exposed to the sterile filtrate of mutant 1615:tnp6w appeared identical
to those exposed only to sterile M7H9 + OADC (Figure 13). The sterile filtrate of mutant
1615:tnp3 had a cytopathic effect on the fibroblasts identical to that of the wild-type M
uclerans (Figure 14).

In order to more definitively determine if mutant 1615:tnp6w was producing
mycolactone, its ASLs were subjected to mass spectral analysis. The mass spectrum of
ASLs of wild-type M ulcerans 1615 have a sharp peak at mlz 765.5, which represents
mycolactone, and a peak at mlz 445.3, which represents the core lactone (Figure 15).
There are no comparable peaks present in the mass spectrum of the ASLs of mutant
1615:tnp6w (Figure 16). The absence of peaks at m/z 765.5 or at mlz 445.3 is indicative
that neither mycolactone nor core lactone is produced by this mutant.
Having established mutant 1615:tnp6w to be negative for mycolactone
production, efforts to determine the location of the transposon were undertaken. A .8%
agarose gel for Southern blot was prepared with overnight Sad, Pvull, and EcoRI
digestions of mutant 1 6 1 5:tnp6w genomic DNA. As a negative and positive control
(respectively), EcoRI digestions of genomic DNA from M ulcerans 1615 and an
™

Escherichia coli strain known to have an insertion of the EZ::TN <KAN-2>Tnp

transposon were also included. Hindlll cut A DNA ladder and 1 kb DNA ladder were
included in the gel. The Southern blot was prepared as instructed by the ECL™ Direct
Nucleic Acid Labelling and Detection Systems kit to be used to probe and develop the
blot. The blot was washed, pre-hybridized, and hybridized as instructed by the kit. 100
ng of a 1,108 bp region of the transposon was labeled using a proprietary labeling reagent
42

Figure 13. L929 murine fibroblasts after exposure to sterile filtrate of mutant
1615:tnp6w.

Picture was taken at 48 hours and 1 00
undisturbed.

x

magnification. Cells appear phenotypically

Figure 14. L929 murine fibroblasts after exposure to sterile filtrate of mutant
1615:tnp3.

Picture was taken at 48 hours and 1 00

x

magnification.
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Figure 15. Mass spectrum of M. ulcerans 1615 ASLs.
The large, sharp peak at mlz 765.5 is known to represent mycolactone, the most abundant
species present; while, the peak at mlz 445.3 is known to represent the core lactone.

44

2: MS, Time-0.03449-0.7084min (#3-#60). 100%=637440a1

Abund.

409.2

1 00

80

453.1

349.2

60

40 :
5.2

497.2

20 617.5
675.7 70�-7

400

700

500

74f.7

800

m/z

Figure 16. Mass spectrum of M. ulcerans 1615:tnp6w ASLs.
The absence of a peak at mlz 765.5 indicates that mycolactone is not produced by this
organism. In addition, there is no peak at mlz 445.3, the peak which is known to
represent the core lactone.
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followed by a glutaraldehyde solution as described by the kit and was used to probe the
blot. The blot was developed chemically using proprietary developing reagents included
in the kit. Hybridization by the probe was detected by exposing the blot to film for
several minutes. Single, distinct bands were hybridized by the transposon
complementary probe for both the genomic mutant 1 6 1 5 :tnp6w genomic DNA digested
with Pvull and that digested with EcoRI, indicating that the transposon is present in only
one copy (i.e., one insertion) in the genome of the mutant (Figure 17). These bands
migrated from the well 22 mm and 1 1 mm, respectively. There was no clear band
hybridized to the probe in the lane corresponding to the mutant genomic DNA digested
with Sad-only a high molecular weight smear. This can be attributed to incomplete
digestion as was also evidenced by the picture of the gel taken before blotting (not
shown). As expected, the probe hybridized to a distinct area corresponding to the
genomic DNA of the E. coli transposon insertion mutant-the positive control-but did
not hybridize to that of M. ulcerans 1 6 1 5-the negative control. Linear regression
analysis revealed that the transposon is located in the mutant 1 6 1 5 :6w genomic DNA on
a fragment of DNA of approximately 6.5 1 kb in a Pvull digestion and a fragment of
approximately 1 5 .39 kb in an EcoRI digestion.
In an effort to determine what gene had been interrupted by the insertion of the
transposon in the mutant 1 6 1 5 :tnp6w, several attempts at sequencing directly from the
genomic DNA were made. These attempts were unsuccessful. Next, many attempts to
clone the transposon with its flanking regions of genomic DNA to be sequenced from the
newly created plasmid were made by both the shotgun method and by attempting to
isolate and clone only the 6.5 1 kb Pvull fragment of genomic DNA. These also were
46

-=
-.s-

�

"O

-- ;
-= '8.-= -=

�
�
�
--..;

\,Q

c.,

vi
�
\,Q
�

::s
�
�

vi
�
\,Q
�

�
�
�

;�

vi
�
\,Q
�

�

-.....;

\,Q

c.,

=

�

-.....;

c.,

0y

r-l

;�

�
I()
�
\,Q
�

-.....;

a.
"O
"O

�
�

:e�

Figure 17. Film exposed by the Southern blot of mutant 1615:tnp6w genomic DNA
probed with a probe complementary to a 1.1 kb region of the transposon.
Digestion of 1 6 1 5 :tnp6w genomic DNA with SacI was incomplete. A single band of
PvuII digested genomic 1 6 1 5 :tnp6w DNA of approximately 6.5 kb was hybridized by the
probe; while, a single band of EcoRl digested genomic 1 6 1 5 :tnp6w DNA of
approximately 1 5.39 kb was hybridized by the probe. EcoRl digested genomic DNA
from E. coli:tnp, a confirmed transposon insertion mutant, and from wild-type M
ulcerans 1 6 1 5 were used as a positive and negative control, respectively.
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unsuccessful.
To obtain sequence data from the regions of genomic DNA flanking the
transposon, a two part arbitrarily primed PCR technique was employed. The first round
of PCR utilized a primer 150 bp within the transposon and a random primer containing
sequences common in mycobacteria. This PCR reaction produced DNA fragments of
varying lengths, all flanking the transposon (and containing over 100 bp of it). The
second round of PCR in this arbitrarily primed PCR protocol used the first round
products as template and an arbitrary (rather than random) primer which was nearly
identical to the random primer with out the random bases. The second primer used in this
reaction was a primer complementary to the transposon in a region 50-100 bp within the
transposon. This amplified many fragments of DNA of the same length flanking the
tranposon. This concentrated amplification of DNA adjacent to the transposon was
sequenced using the sequencing primers included in the transposon kit.
The sequence obtained from the reactions which amplified DNA downstream of
the transposon was poor; and, when a Blast search was performed, no strong homologies
were identified. The sequence obtained for the DNA upstream of the transposon,
however, was 97% identical to the M marinum ferric uptake regulator homolog (FurA)
gene and 89% identical to the same gene (furA) of M tuberculosis. The arbitrarily
primed PCR protocol was repeated and the final products sequenced. The sequences
obtained were identical to the ones previously obtained. At this time, it was uncertain
where the transposon was inserted in relation to the furA homologue of M ulcerans.
Several months after this mutant was found to have an insertion in the furA
homologue of M ulcerans, Dr. Armand Mve-Obiang independently identified a second
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mycolactone-negative mutant (mutant 97) which also has an insertion in the same gene.
This reinforced the suspicion that thefurA homologue of M ulcerans could be a
regulator of mycolactone. For complementation studies, the sequence of the M marinum

furA homologue was obtained and used to search the Burulist database
(http://genopole.pasteur.fr/Mulc/BuruList.html}, a database organized by the Pasteur
Institute to allow access to the unannotated genomic DNA sequences of M ulcerans, for
the M ulcerans homologue of furA. This database identified thefurA homologue of M

ulcerans to be on a 7.6242 kb contig designated mu0181G02F PhrapUL 7.6242. The
entire sequence of this contig was obtained from Dr. Tim Stinear (Pasteur Institute, Paris,
France) and within it the furA homologue was identified. At this time, the sequence data
obtained from the forward and reverse products of the arbitrarily primed PCR protocol
were pieced together and compared to the sequence of this region available in the contig.
The transposon insertion of mutant 1615 :tnp6w appeared to be located, not in the actual
structural gene ofthefurA homologue, but approximately 270 hp upstream of this gene.
This region of DNA is not homologous to any know prokaryotic genes and could be a
noncoding region of the M ulcerans genome.
The sequence obtained from the mu0181G02F PhrapUL 7.6242 contig was used
to create primers to amplify the furA homologue of M ulcerans and approximately 500
hp upstream and downstream of the gene. These primers were used to amplify the
corresponding region of DNA of wild-type M ulcerans 1615. This region of DNA was
cloned into the shuttle vector pPR27HI and the construct used to complement the mutant
1615 :tnp6w and mutant 97. Several transformants were obtained when the mutant
1615 :tnp6w was electroporated with this construct. (No mutant 97 transformants were
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obtained.) However, after several months incubation, none of the transformants had
turned yellow. Cytotoxicity assays on L929 murine fibroblasts treated with sterile filtrate
of the transformants revealed that the transformants did not produce any cytotoxic
compounds present in the media.
In search of an explanation for the lack of mycolactone production upon
complementation of the mutant:tnp6w with thefurA homologue of M ulcerans, this
mutant was analyzed via PCR for the presence of two genes, one encoding an enoyl
reductase and the other a thioesterase (11), recently identified to be essential for the
production of mycolactone. These genes are in areas of genetic instability and are
thought to be frequently lost due to recombination. While mutant 97 contained both of
these genes as evidenced by the PCR reaction, the thioesterase was not present in the
mutant 1615:tnp6w. The mutant 1615:tnp6w had a mycolactone-negative phenotype due
to the deletion of the thioesterase (11) gene required for mycolactone production, rather
than the insertion in thefurA homologue. However, the possibility of the FurA
homologue of M ulcerans playing a role in the regulation of mycolactone production can
not be eliminated.

Discussion

Through many attempts over many months to create mycolactone-negative
mutants of M ulcerans through transposon mutagenesis, only a total of five PCR
confirmed insertion mutations arose. This can be contributed to the extremely low
transformation efficiency of M ulcerans combined with the statistical improbability of
transposition. While it might seem highly fortuitous to some that a mutant of the
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phenotype desired--a mycolactone-negative mutant-would be present in a pool of only
five insertion mutants; constructing a mycolactone-negative mutant of M ulcerans was
not seen as an endeavor that would require the production of large libraries of mutants.
At the time of this study, based on the knowledge of other polyketides, it was
hypothesized that the genetic elements required for the synthesis of mycolactone would
be comprised of more than 100 kb of DNA and would include two polyketide synthase
(PKS) genes, an acyl transferase, and a p450 hydroxylase. For this reason, it was not
surprising that in even a small pool of insertion mutants there appeared to be a mutant
with an insertion in such a large genetic target.
The putative mycolactone-negative mutant was recognized as such by its lack of
pigmentation. Wild-type M ulcerans has a very obvious yellow color which was thought
to be due to the presence of mycolactone, a compound with the conjugated double bonds
that cause molecules to be pigmented. Strains of M ulcerans that had spontaneously lost
pigmentation after repeated culturing in the lab had been found to be mycolactone
negative. The putative mycolactone-negative insertion mutant remained white after
many months of growth. All other insertion mutants obtained were yellow and have
remained so. To rule out the remote possibility that the putative mycolactone-negative
mutant was not M ulcerans but some contaminant, the mutant was verified by PCR to
have the IS2404 insertion element, a genetic element unique to M ulcerans.
The predominant species of mycolactone produced by M ulcerans 1 6 1 5, the
strain from which the insertion mutants originated, is know to have an Rr value of
approximately .23 when analyzed via TLC using the solvent system used in these
experiments. To analyze the composition of the ASLs of mutant 1 6 1 5 :tnp6w and to
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determine if they contained mycolactone or any molecules of similar size and polarity,
the ASLs of a log-phase culture were isolated and analyzed via TLC using the ASLs of
phenotypically normal transposon insertion mutant 1615 :tnp3 and wild-type M ulcerans
as controls. While the ASLs of the mutant 1615 :tnp3 contain a band at approximately Rr
.23 as do the ASLs of M ulcerans 1615 this band or one comparable to it is not present in
the ASLs of the mutant 1615:tnp6w.
Though by TLC analysis of ASLs, mutant 1615 :tnp6w appeared to be
mycolactone-negative, cell cytotoxicity assays were performed on the sterile filtrate of
this mutant using L929 murine fibroblasts. The sterile filtrates of M ulcerans 1615 and
mutant 1615:tnp3 were used as positive controls; while, sterile M7H9 + OADC was used
as a negative control. Mycolactone, which is present in the sterile filtrate of strains that
produce it, is known to cause cell cycle arrest in fibroblasts by rearrangement of the
cytoskeleton. In cell culture, this is made apparent by rounding of the cells followed by
their detachment from the monolayer. This affect, as expected, was seen in cells treated
with the sterile filtrate of both M ulcerans 1615 and the phenotypically normal mutant
1615 :tnp3; however, the sterile filtrate of mutant 1615 :tnp6w produced no such effect,
and after 48 hours cells treated with it looked identical to cells treated with sterile M7H9
+ OADC. Similar assays (not shown) on the ASLs of this mutant 1615 :tnp6w produced
identical results. It is clear that mutant 1615 :tnp6w is not cytotoxic.
To definitively prove that this mutant does not produce mycolactone, its ASLs
were analyzed via mass spectroscopy. The mass spectrum of mutant 1615 :tnp6w did not
have peaks at either mlz 765.5 or mlz 445.3, which represent mycolactone and its core
lactone, respectively. It should also be noted that the mass spectrum of the ASLs of this
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mutant did not have any peaks which represent any of the less common congeners of
mycolactone. Mutant 1615:tnp6w is clearly mycolactone-negative as evidenced by this.
™

Though the EZ::TN <KAN-2>Tnp transposon is designed so that sequence data
can be obtained by sequencing out from either end of the transposon directly from
genomic DNA, this was not feasible with M ulcerans. M ulcerans has an extremely
GC-rich genome, and sequencing directly from the genome is further complicated by the
inability to isolate high concentrations of clean genomic DNA from this organism. After
several attempts at obtaining sequence data directly from the genome, new approaches
were considered. Many attempts at shotgun cloning using various enzymes and vectors
were unsuccessful. The Southern blot of Pvull and EcoRI digested mutant 1615:tnp6w
genomic DNA revealed that when digested with these enzymes, the fragment containing
the transposon was approximately 6.5 kb and 15.4 kb, respectively. While the 15.4
EcoRI fragment might be difficult to clone, the smaller 6.5 kb Pvull was thought to be
readily clonable. Many attempts at digesting mutant 1615:tnp6w genomic DNA with
Pvull, running the DNA on a gel, excising the bands of DNA corresponding to
approximately 6.5 kb, extracting the DNA from a gel and ligating the DNA to a Pvull cut
vector were unsuccessful. It is very difficult to isolate from M ulcerans the large
quantities of DNA needed for cloning and even more difficult to isolate unsheared, pure
DNA from this organism. This lack of DNA was exacerbated by the need to purify DNA
from a gel. Several methods for doing this were tried and compared. All result in the
loss of a significant percentage of the DNA to be isolated. The inability to to obtain
sequence data from direct sequencing or from cloning the transposon containing fragment
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necessitated alternative methods for determining which gene had been interrupted by the
insertion of the transposon.
The arbitrarily primed PCR protocol proved to be a very useful tool for
identifying the gene which had been interrupted by the transposon. With this method,
sequence data was obtained that suggested that the transposon had inserted into the furA
homologue of M ulcerans. Not long after it was determined that the transposon had
possibly interrupted the furA homologue of M ulcerans, an independently created
mycolactone-negative mutant (mutant 97 from Dr. Armand Mve-Obiang) was also found
to have a single interruption in the same gene. This was the impetus to continue
characterization of this mutant after discovering that the gene which was interrupted-the
furA gene-was most likely not directly involved in the synthesis of mycolactone.
The FurA protein of M marinum is an orthologue of the E. coli transcription
factor Fur (ferric uptake regulation). The fur genes of M tuberculosis are thought to be
transcriptional regulators of genes involved in functions other than acquisition of iron
(14). In mycobacteria,/urA is ubiquitously linked to the catalase-peroxidase gene katG
and has been shown to be a negative regulator of katG (60, 86). It is thought thatfurA
may regulate virulence factors other than katG.
Complementing the mutant 1615 :tnp6w with thefurA homologue of M ulcerans
did not result in the production of mycolactone; however, mutant 97 was not able to be
transformed. Via PCR analysis, the lack of restored mycolactone production in mutant
1615 :6w has been explained by a deletion in the thioesterase (II) encoding gene which
has recently been identified as essential for mycolactone production (73). This deletion
is most likely the cause of the mycolactone-negative phenotype, rather than the insertion
54

of the transposon into the furA homologue of M ulcerans. Electroporation is associated
with increased mutation rates and may have caused this deletion in the thioesterase (II).
It should also be noted thatfurA, possibly functioning as an iron uptake regulator in M
ulcerans, could protect the cell from damage due to excess iron. It is possible that in a
FurA-minus mutant, increased levels of iron within the cell would lead to an increased
mutation rate. The possibility that FurA plays some role in the regulation of mycolactone
can not be ruled out at this time.
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IV. Optimization of the Electroporation Efficiency of Mycobacterium

ulcerans and Mycobacteriumfortuitum

Introduction

The development of the electroporation technique--in which electrocompetent
bacterial cells are subjected to a brief, strong electrical impulse which permeabilizes their
membranes, allowing them to take-up DNA--was a great advance in the field of genetic
engineering. The electroporation protocol developed for use with mycobacteria was
based on the traditional protocols which are generally highly effective when used on
other genera of bacteria (61). These protocols require that cells are washed and remain
at 4C at all times to achieve optimal transformation efficiencies (30). Such technique
has been found comparably effective for the transformation of Mycobacterium smegmatis
and possibly other fast-growing mycobacteria (40, 61, 83). However, for other strains of
mycobacteria, transformation efficiencies achieved with these techniques are
significantly lower. With M ulcerans, these techniques are not effective at all. There are
no published reports of successful electroporation into M ulcerans; nevertheless,
electroporation is considered the best method of transformation for any mycobacteria
(40). An effective electroporation protocol is greatly needed for M ulcerans. Without
this tool, prolific complementation studies and studies implementing transposition
mutagenesis are impossible.
In 1996, Wards and Collins published a study demonstrating that M bovis cells
prepared for electroporation at room temperature have a significantly higher
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transformation efficiency than those washed at the traditional 4t (83). In 2000, Talaat
and Trucksis, found that the same is true for M marinum (74). In addition, Wards and
Collins also demonstrated that for M bovis, M tuberculosis, and M intracel/ulare the
highest electroporation efficiencies are achieved when the cells are electroporated at 3 7t;
while, for M smegmatis, the highest electroporation efficiencies are achieved when the
cells are electroporated at the traditional 4t (83).
The following experiments were performed to determine the effect of the
temperature of the cell at the time of electroporation on transformation efficiency in M
ulcerans. The findings of these studies were then tested on the faster growing M
fortuitum, another atypical mycobacteria for which high transformation efficiency is not
readily achieved. Studies are also described here which are aimed at determining the
effect of mycolactone on the electroporation efficiency of M ulcerans.

Results

There have been no published accounts of successful transformation into M
ulcerans. Transformation of M ulcerans at the time this study was begun had been
achieved, though with minimal success, only by washing cultures of M ulcerans grown
in Middlebrook 7H9 with 10% oleic acid-albumin-dextrose-complex (M7H9 + OADC)
with ice-cold 10% glycerol and electroporating the resulting cells at 4t with parameters
set at 2.5 kV, 800 n, and 25 µF, parameters similar to those used with other
mycobacteria. Because electroporation at higher resistances has been shown to result in
higher efficiencies in other species, the number of transformants obtained by
electroporating three identical aliquots of 10% ice-cold glycerol washed M ulcerans at
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each of 800 n, 900 n, and 1000 n resistance was compared. For each pulse, capacitance
and voltage were held constant at 25 µF and 2.5 kV, respectively. All steps were carried
out at 4t. Immediately after electroporation, cells were transferred to 2 mL of M7H9 +
OADC and placed in a rollerdrum at 32t. After 72 hours, the cells were plated on
selective media. None of the nine aliquots resulted in a single transformant. As a result,
it can not be determined with certainty at which resistance the electroporation efficiency
of M ulcerans would be highest. However, it is likely that the highest electroporation
efficiency would occur with electroporations at 800 n resistance. Arcing seemed to
increase with an increase in resistance. All samples pulsed at 1000 n arced; while, only
one arced when pulsed at 900 n. None of the samples arced when pulsed at 800 n.
Arcing is known to greatly decrease electroporation efficiency in other species of
mycobacteria, because it results in massive cell death. This seems to be true for M
ulcerans as well. M ulcerans cells plated on non-selective media after an arcing pulse
took six weeks to grow up (compared to four weeks for cells subjected to a non-arcing
pulse) and failed to form a lawn on the plate as was seen on the non-selective media
plates of a non-arcing pulse. These observations of greatly decreased survival of M
ulcerans subjected to arcing compared to M ulcerans subjected to a non-arcing pulses
suggests that the resistance least likely to result in arcing, 800 n, should be used. All
subsequent electroporation experiments with M ulcerans were carried out with pulses of
the parameters 2.5 kV, 800 n, and 25 µF. It was determined that it was imperative to
examine factors other than resistance which may improve electroporation efficiency in M
ulcerans.
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The Effect of Temperature on Electroporation Efficiency

M ulcerans cells had previously been washed at 4t as prescribed by
protocols for the preparation of electrocompetent cells of nearly all other bacteria;
however, two studies had been published demonstrating that electroporation efficiencies
of M bovis and M marinum increase when the cultures are washed at room temperature
(74, 83). In a preliminary electroporation study to determine if an increase in temperature
of the M ulcerans cells at the time of electroporation would result in a higher
transformation efficiency, a method for preparing electrocompetent M ulcerans at room
temperature was tested. The cells of a 400 mL culture of M ulcerans were harvested and
washed at room temperature with successively smaller volumes of room temperature
10% glycerol. The final pellet was resuspended in 2 mL of 10% glycerol and the cells
were apportioned into 60 µL aliquots. Three aliquots were held at each of three
temperatures, 1) 4t, 2) room temperature, and 3) 37t, for 10 minutes prior to their
electroporation with 1 µL (of a stock at a concentration of .3 µg/µL) of the hygromycin B
resistance conveying plasmid pPR27HI. No arcing occurred with incubation at any
temperature with these room temperature washed cells. Immediately after
electroporation the cells were transferred to 2 mL pre-warmed M7H9 + OADC and
incubated in a rollerdrum at 32C for 72 hours. After this time, the cells were plated on
selective media. Though transformants appeared by 6 weeks of incubation, colony
counts were made at 8 weeks of incubation (Table 1). No transformants resulted from
cells electroporated after incubation at either 4C or room temperature; however, both
trials after incubation at 37C produced transformants.
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Table 1. The number of transformants resulting from the electroporation of M.
ulcerans grown in M7H9 + OADC after incubation at 4t, room temperature, and
37t after prepara�on at room temperature.
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In a subsequent experiment to further investigate the effect of temperature on
electroporation efficiency, the cells of a 250 mL culture of M ulcerans 1615 grown in
M7H9 + OADC were harvested, washed at room temperature with 10% glycerol, and
aliquoted as described previously. Five aliquots of approximately 5 x 105 cells each (one
control and four experimental) were held at room temperature (25t), 37t, 40t, and 45·c
for ten minutes prior to electroporation with 1 µg (concentration of 1 µg/µL) of the
hygromycin B conveying plasmid pPR27HI. After electroporation, the cells were
incubated at 32t in a rollerdrum for 72 hours before being plated on selective media as
described previously. Controls plated on non-selective media grew up within four weeks;
while, many transformants appeared by six weeks. After eight weeks, the transformants
were counted (Figure 18). Cells electroporated after incubation at 25· C had any average
of 6 transformants/µg of DNA; while, those electroporated after incubation at 37t had an
average of 23 transformants/µg of DNA-a small but significant increase in
electroporation efficiency. Cells electroporated after incubation at 40t had an average
transformation efficiency of approximately 45 transformants/µg of DNA; while, those
electroporated after incubation at 45t had an average transformation efficiency of
approximately 39 transformants/µg of DNA. However, due to great variability in the
number of resulting transformants among aliquots electroporated after incubation at 40C
and 45t, there was no significant increase in transformation efficiency after incubation at
either of these temperatures when compared to those electroporated after incubation at
37t. However, with cells electroporated after incubation at 55t, which had an average
transformation efficiency of 159 transformants/µg of DNA, there was a significant
increase in transformation efficiency. There were no spontaneous hygromycin resistant
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Figure 18. Average number of transformants resulting from electroporations of M.
ulcerans grown in M7H9 + OADC at each temperature.
Average was computed from sample size n = 3. Error bars represent ± 1 standard
deviation.
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mutants arising from any of the cells electroporated after incubation at each temperature
without pPR27HI; however, the transformants were confirmed via PCR amplification of
the hph hygromycin resistance gene contained on the plasmid.
To determine if the trend of increased electroporation efficiency after incubation
at higher temperatures could be applied to improve the electroporation efficiencies of
other atypical mycobacteria, this experiment was repeated using M fortuitum grown in
M7H9 + OADC.

M fortuitum is another atypical mycobacterium for which there is no

published protocol for transformation. M fortuitum, like M ulcerans, has a lipid-rich
cell wall; however, unlike M ulcerans, it is considered a fast grower, reaching log phase
in three to four days. This is a particularly attractive characteristic to those who would
like to express mycolactone (and perhaps other products of slow growing mycobacteria)
in M fortuitum to decrease the time required for its production; however, M fortuitum
can not be useful for such purposes until it can be efficiently transformed. M fortuitum
cells were harvested, washed, and aliquoted as described for M ulcerans (approximately
5 x 105 cells). The cells were electroporated with 1 µL of DNA (at a concentration of 1
°

µg/µL) after incubation for 10 minutes at room temperature (25C), 37t, 40t, and 45 C at
2.5 kV, 25 µF, and 800 n. After electroporation, cells were transferred to 2 mL M7H9 +
OADC and shaken for 5 hours at 37t. Because M fortuitum was found to be resistant to
hygromycin B, the aparamycin resistance conveying plasmid pYUB 185 had to be used
rather than pPR27HI. Therefore, transformants were selected on M7H9 + OADC with 30
µg/mL aparamycin and appeared after 5 days of incubation at 37t (Figure 19). The
average number of transformants for cells electroporated after incubation at 4C was
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M. fortuitum Grown in M7H9 + OADC
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Figure 19. Average number of transformants resulting from electroporations of M.
fortuitum grown in M7H9 + OADC at each temperature.
Average was computed from sample size n = 3 . Error bars represent ± 1 standard
deviation.
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2 transformants/µg of DNA; while, that for cells electroporated at 25t was approximately
11 transformants/µg of DNA. A further increase in electroporation efficiency was seen
with cells electroporated at 37t, which had an average number of transformants of
approximately 21 transformants/µg of DNA. The electroportation efficiency of cells
electroporated after incubation at 45t, approximately 1,173 transformants/µg of DNA,
was greater than ten-fold higher than that of cells electroporated after incubation at 40t,
106 transformants/µg of DNA.
The Effect of Mycolactone on Electroporation Efficiency

Though the increase in electroporation efficiency of M ulcerans achieved
by increasing the temperature of the cells at the time of electroporation are a marked
improvement, efficiencies of 102 transformants/µg of DNA pale in comparison to the 106
and higher transformants/µg of DNA transformation efficiencies of other bacteria. Other
methods of improving the electroporation efficiency of M ulcerans need to be explored.
It is thought that a great hindrance to transformation of M ulcerans is its thick,
polyketide-enriched cell wall. Because mycolactone is thought to be a major constituent
of this cell wall, experiments were undertaken to determine the effect of mycolactone on
electroporation efficiency. Mycolactone has been found to constitute approximately 1020% of the total ASLs produced by a given M ulcerans culture. Previous studies in the
lab suggested that M ulcerans grown in either Sauton's synthetic medium or Reid's
synthetic medium produces significantly less ASLs (and therefore less mycolactone) than
M ulcerans grown in M7H9 + OADC;while, M ulcerans grown in M7H9 with 20%
OADC supplement (M7H9 + 2[OADC]) produces significantly more ASLs (and
therefore mycolactone). To determine the effect of mycolactone on electroporation
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efficiency, 500 mL cultures of M ulcerans grown in Sauton's synthetic media, Reid's
synthetic media, M7H9 + OADC, M7H9 + 2[OADC], and of a mycolactone-negative M
ulcerans PKS knock-out mutant 115 grown in M7H9 + OADC were divided into two 250
mL portions: one portion to be subjected to the electroporation experiment described
above aimed at determining the effect of temperature on the electroporation efficiency of
M ulcerans and acetone soluble lipids (ASLs) to be extracted from the other portion. For
the electroporation experiment, cells were harvested, washed, and aliquoted as described
above. Five aliquots (one control and four experimental) of approximately 5 x 10 5 cells
each were held at room temperature (25t), 37t, 40t, and 45t for 10 minutes prior to
electroporation with 1 µL (concentration 1 µg/µL) of the hygromycin B resistance
conveying plasmid pPR27HI with a single pulse of constant parameters (2.5 kV, 25 µF,
and 800 fl). (M ulcerans grown in M7H9 + OADC was also electroporated after
incubation at 55t.) Because a previous study (data not shown) demonstrated that cells
from M ulcerans cultures grown in Sauton's or Reid's synthetic medium were more
likely to recover if transferred to M7H9 + OADC (than the medium in which they were
grown) and then plated on M7H 1 0 + OADC, cells were transferred to 2 mL M7H9 +
OADC immediately after electroporation. After 72 hours of incubation in a rollerdrum at
32C, the cells were plated on selective media.
In order to isolate ASLs, total lipids were extracted with chloroform:methanol
(2:1, vol/vol). After drying off the chloroform:methanol under nitrogen, ice-cold acetone
was added to the desiccated lipids. ASLs were resuspended in the acetone and
transferred to another vial along with the acetone. The total ASLs extracted were massed
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(Table 2), and approximately 60 µg of each was analyzed via thin-layer chromatography
(TLC) (Figure 20).
Though all non-selective plates contained growth within eight weeks, no
transformants resulted from the electroporations of cells grown in either Sauton' s or
Reid's synthetic medium. The number of transformants obtained for M ulcerans grown
in M7H9 + OADC is shown in Figure 21 and was discussed previously; while, the
number of transformants obtained for M ulcerans grown in M7H9 + 2[OADC] is shown
in Figure 21. While M ulcerans cultures grown in Reid's and Sauton's synthetic media
do produce less mycolactone, they do not produce transformants when electroporated
after incubation at any temperature. These media are not appropriate for growing
cultures for transformation. The same was true for the mycolactone-negative PKS
mutant 115 of M ulcerans. While M ulcerans grown in M7H9 + 2[OADC] does seem
to produce more mycolactone than M ulcerans grown in M7H9 + [OADC], the number
of transformants resulting from cells grown in M7H9 + 2[OADC] electroporated after
incubation at 25t, 37t, and 40t is not significantly different from the number of
transformants resulting from cells grown in M7H9 + [OADC] at those same
temperatures, respectively. However, the average transformation efficiency of cells
grown in M7H9 + 2[OADC] and electroporated after incubation at 45·c (approximately
119 transformants/µg of DNA) is nearly three-fold that of cells grown in M7H9 + OADC
(approximately 39 transformants/µg of DNA).
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Table 2. The mass of total ASLs isolated from 250 mL of each culture.

Mass of Total ASLs Isolated
From 250 mL of Culture
(mg)

Culture

M ulcerans mutant #115, a PKS
knock-out mutant

.7847

M ulcerans Grown in Reid' s
Synthetic Medium

2.7456

M ulcerans Grown in Sauton' s
Synthetic Medium

2.5867

M ulcerans Grown in M7H9 +
OADC

3.5133

M ulcerans Grown in M7H9 +
2[0ADC]

5.3447
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Figure 20. TLC analysis of ASLs isolated from a mycolactone-negative M. ulcerans
PKS knock-out mutant 115 grown in M7H9 + OADC, M. ulcerans grown in Reid's
synthetic media, Sauton's synthetic media, M7H9 + OADC, and M7H9 + 2(OADC].
ASLs were resuspended in acetone, and approximately 60 µg of each was loaded. The
standard is 30 µg of previously isolated ASLs. The solvent system used was 90: 1 0: 1
chloroform:methanol:water (vol:vol:vol).
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M. ulcerans Grown in M7H9 + 2 [0ADC]
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Figure 21. Average number of transformants resulting from electroporations of M.
ulcerans grown in M7H9 + 2[0ADC] at each temperature.

Average was computed from sample size n = 3. Error bars represent ± 1 standard
deviation.
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Discussion

The attempts to construct a mycolactone-negative mutant of M ulcerans via
transpon mutagenesis discussed in the previous chapter were greatly hindered by the poor
transformation efficiency of M ulcerans. For transposon mutagenesis to be a valuable
tool with regard to this organism, it was necessary to determine the parameters under
which transformation could consistently be carried out. In addition, it was certain that a
reliable method for transforming M ulcerans would be highly useful, if not necessary, in
future genetic analysis of this organism. While electroporation is considered the best
method of transformation for any mycobacteria, including M ulcerans; there are no
published reports of successful electroporation into it (40). At the time these studies
were begun, the electroporation efficiency of this organism was effectively 0
transformants/µg of DNA. A round of electroporation utilizing all aliquots of M
ulcerans obtained from the washing of a 500 mL culture would yield a total of less than
ten transformants but often none at all.
Initially, it was necessary to determine what parameters of the pulse used in
electroporation would yield the highest transformation efficiencies. Previously, several
transformants of M ulcerans had been obtained at Rocky Mountain Laboratories through
electroporation at 2.5 kV, 25 µF, and 800 n, parameters used for the electroporation of
M tuberculosis and other related species. Because it is known that for other species
higher resistances generally yield higher electroporation efficiencies as long as they do
not result in arcing, the task of determining if a higher resistance used on M ulcerans
would yield a higher electroporation efficiency was undertaken. Because even small
amounts of impurities in DNA stocks can lead to arcing due to increased conductivity, it
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is important to use the smallest volume of DNA possible during each pulse, usually 1 µL.
Three sets of three identical aliquots each of 10% glycerol washed M ulcerans were
™

™

electroporated with 1 µL of EZ::TN <KAN-2>Tnp Transposome at constant
capacitance and voltage, but a resistance of 800 n, 900 n, or 1000 n. This experiment
yielded no transformants; therefore, it could not be determined with certainty which
resistance would be best to use in future experiments. Every aliquot pulsed at 1000 n
arced; while, one aliquot pulsed at 900 n arced. The sparse and greatly delayed growth
on the non-selective control plates of the aliquots subjected to arcing indicated that
massive cell death occurs among M ulcerans cells exposed to arcing during
electroporation as it does for other species. As in other species, massive cell death is
likely to greatly decrease electroporation efficiencies. It was decided to use 800 n
resistance in all subsequent experiments; because, there was no arcing when pulsing the
aliquots at this resistance, and non-selective control plates developed lawns within four
weeks, demonstrating that the cells could recover when pulsed at this resistance.
In the preliminary experiment to determine if the temperature of the M ulcerans
cell at the time of electroporation might influence electroporation efficiency, aliquots of
electrocompetent M ulcerans were held at three temperatures, 1) 4t, 2) room
temperature, and 3) 37t, for 10 minutes prior to electroporation with .3 µg of the
hygromycin B resistance conveying plasmid pPR27HI. No transformants resulted from
aliquots electroporated after incubation at either 4t or room temperature. Though for
statistical purposes more trials were needed, the results of this experiment suggested that
an increase in temperature results in an increase in electroporation efficiency. The
electrocompetent cells used in this experiment were prepared at room temperature.
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Because no arcing occurred during this experiment, it appeared that washing cells at
room temperature is at least as effective at producing electrocompetent cells as washing
on ice at 4t. Washing cells at room temperature is a more convenient method, because it
can be done without ice. It should also be noted that M ulcerans cells are less likely to
clump together at a warmer temperature, making them easier to manipulate at room
temperature than at 4t. Salts, which cause arcing, are trapped in clumps; therefore, the
salts within non-clumped cells can be removed more efficiently than those within
clumped cells. Electrocompetent M ulcerans cells were prepared at room temperature
for all subsequent experiments and were never again electroporated at 4t.
In the following experiment, a higher range of temperatures was used and more
aliquots were electroporated at each temperature. The data obtained from this experiment
suggests that to obtain the optimal electroporation efficiency, M ulcerans should be
electroporated after incubation at 55t. Cells electroporated after incubation at 37t
showed a slight but significant increase in electroporation efficiency when compared to
those electroporated after incubation at 25t. While cells electroporated after incubation
at 40" C and 45· C both had higher average number of transformants/µg of DNA than those
electroporated after incubation at 37t, this increase was not statistically significant due to
the great variability among the number of transformants which arose from each aliquot.
The average number of transformants which arose from electroporations after incubation
at 55t was five-fold higher than that achieved after incubation at 37t. Further tests
might be valuable to determine if even higher temperatures may increase electroporation
efficiency more; however, in a separate study (data not shown), M ulcerans cells held at
65t for ten minutes prior to electroporation were completely killed. (I.e., They failed to
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grow-up at all, even on non-selective M7H9 + OADC.) Therefore, it is likely that a
temperature which after incubation at induces a higher electroporation efficiency, if not
55t, is between 55t and 65t.
Electroporation efficiencies of over 100 transformants/µg of DNA achieved when
cells are electroporated after incubation at 55t represent an enormous improvement over
the very poor and unreliable electroporation efficiencies (always less than 10
transformants/µg of DNA and often none at all) achieved with the protocols used at the
time this study was begun. It is likely that increasing temperature of the M ulcerans cell
increases the fluidity of lipids in the cell wall. Though usually impervious to the effects
of electroporation, the M ulcerans cell wall of increased fluidity would be more likely
upon electroporation to form the pores necessary for transformation. This phenomenon
of increased electroporation efficiency with increased temperature of the cell was tested
for another atypical mycobacteria with a lipid-rich cell wall-M fortuitum. A similar
trend was seen for M fortuitum, also a bacterium for which a reliable electroporation
protocol has not been developed. For this bacterium, the electroporation efficiency after
incubation at 45t, approximately 1,173 transformants/µg of DNA, was greater than ten
fold higher than that after incubation at 40t, 106 transformants/µg of DNA.
It is thought that a great hindrance to transformation of M ulcerans is its thick,

polyketide-enriched cell wall. In order to determine if electroporation efficiencies could
be increased by decreasing the amount of lipids and particularly the amount of
mycolactone produced by the organisms, a series of experiments were performed to
compare the mass of ASLs produced by and the electroporation efficiencies of the
following cultures: 1) M ulcerans grown in M7H9 + OADC, 2) M ulcerans grown in
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M7H9 + 2[0ADC], 3) M ulcerans grown in Reid's synthetic media, 4) M ulcerans
grown in Sauton' s synthetic media, and 5) a mycolactone-negative PKS mutant 115 of M
ulcerans. Equal portions of each culture were used to 1) repeat the electroporation
experiment previously described and 2) extract ASLs. As expected, the cultures grown in
Reid's and Sauton' s synthetic media produced a significantly smaller mass of ASLs than
did the cultures grown in M7H9 + OADC; while, the culture of mutant 115 produced an
even smaller mass of ASLs. Also as expected, M ulcerans grown in M7H9 + 2[0ADC]
produced significantly more ASLs than did M ulcerans grown in M7H9 + [OADC].
Despite the decrease in ASL production of cultures grown in Reid's and Sauton' s
synthetic media and the culture of mutant 115 grown in M7H9 + OADC, there was no
increase in electroporation efficiency seen. In fact, no transformants resulted from these
three electroporation studies. However, it can not be said with certainty that a decrease in
mycolactone (and total ASL) production by some other means would not improve
electroporation efficiencies. Sauton's synthetic and Reid's media both lack oleic acid, a
major component of OADC. Including oleic acid in the growth medium of mycobacteria
is known to increase the total percentage of lipids composing the cell (66). This is
thought to account for the increase in ASLs seen for cells grown in M7H9 + 0ADC and
the even greater increase in ASLs for cells grown in M7H9 + 2[0ADC]. It can only be
said with certainty that PKS mutant 115 and wild-type M ulcerans grown in either
Reid's or Sauton' s synthetic media all have electroporation efficiencies far lower than
electroporation efficiencies of wild-type M ulcerans grown in M7H9 + OADC. It should
be noted that mutant 115 appears to have a much slower growth rate than wild-type M
ulcerans 1615, requiring nearly twice as long to reach log phase. It is interesting to note
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that while the M7H9 + OADC and M7H9 + 2[OADC] cultures have comparable
electroporation efficiencies after incubation at 25t, 37t, and 40t, the electroporation
efficiency of the M7H9 + 2[OADC] culture after incubation at 45t is three times that of
the electroporation efficiency of M7H9 + [OADC] culture. An additional experiment has
been performed to determine if there is a significant difference between the
electroporation efficiencies of the two cultures after incubation at higher temperatures
(particularly after incubation at 55t).
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V. The Investigation of a Link between Mycobacterium ulcerans and
Schistosome-Infected Snails

Introduction

The natural reservoir of Mycobacterium ulcerans is unknown. Though many
attempts had been made; at the time this study was begun, M ulcerans had never been
isolated from the environment, not even from Buruli ulcer-endemic foci (19, 69).
Despite this deficiency in evidence needed to construct a complete model of M ulcerans
infection, most researchers believe that M ulcerans infections are in fact acquired from
the natural environment, particularly through small injuries which puncture the skin
allowing the bacteria access to the subcutaneous layer of fat (19, 53, 81). Such injuries
may be so small that the patient may not remember having them by the time the infection
is obvious.
There is significant data to suggest that infection with M ulcerans is acquired
through water. M ulcerans has been detected via PCR from water samples taken in
Buruli ulcer-endemic regions; while, no other environmental samples unassociated with
water have been consistently PCR-positive for M ulcerans (68, 71). However, the theory
that M ulcerans is acquired through contact with contaminated water is more supported
by epidemiological data. One study reported on the high incidence of M ulcerans
infection among Rawandan refugees who had recently settled in the refugee settlement of
Kanyara, Uganda located near marshy areas near the Nile river (47). Buruli ulcer was
not prevalent in Rawanda; so, it was unlikely that the refugees brought the disease with
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them. It was also unlikely that the refugees acquired Bundi ulcer from the other
inhabitants of Kanyara, because there was little contact between the refugees and the
other inhabitants. When the refugees were relocated to Kyangwali, a new area much
further from the marshy land of the Nile, the incidence of Buruli ulcer greatly decreased
within months, then virtually disappeared (2).
Similarly, in 1997 Ross, et al., reported on an outbreak of Buruli ulcer in a small
town on Phillip Isla'.nd of Australia that seemed to be centered around the irrigation
system of a golf course (69). The irrigation system relied on water from a storage dam,
which contained natural ground water and treated wastewater. The outbreak was
preceded by the construction of a road which prevented nearby land from draining
naturally, consequently creating a swamp. Before this outbreak, the town had had no
previous cases of Buruli ulcer. It is believed that this manmade swamp may have
provided a suitable environment for the growth of M ulcerans and contaminated the
irrigation system (69). Both the swamp and irrigation tank were PCR-positive for M
ulcerans; while, other environmental samples were not (69). The incidence of Buruli
ulcer in this town greatly decreased after the source of water for the irrigation of the golf
course was switched to an alternate source (76). These and other epidemiological
studies have led to almost universal acceptance that infection with M ulcerans is
associated with rivers, streams, swamps, lakes, flooding, and possibly other natural and
manmade bodies of water (7, 34, 58).
It is not feasible for people living in Buruli ulcer-endemic regions to prevent the
disease by avoiding contact with bodies of water suspected of harboring M ulcerans,
because they may be dependent on them for their livelihood. If a practical plan for the
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prevention of Buruli ulcer disease is to be created and implemented, more must be
learned about its transmission in relation to water. This objective may be accomplished
through the examination of correlations between Buruli ulcer disease and other factors
related to water. One such factor was noticed in regions of West Africa where the
incidence of Buruli ulcer has increased drastically, especially in areas adjacent to newly
constructed river dams. In these same regions, there has also been a concurrent increase
in schistosomiasis (87).
Schistosomiasis, or Bilharziasis, is an infection caused by digenetic trematodes of
the genus Schistosoma. There are primarily three species which cause disease in humans:
S. haematobium, the most common cause of schistosomiasis in Africa and the Middle
East; S. mansoni, which is prevalent in Africa and Central and South America; and, S.
japonicum, which is prevalent in the Far East (57). Two other less prevalent species of
schistosomiasis are S. intercalatum and S. mekongi, which are limited to West Africa and
South East Asia, respectively (10, 37, 75). Schistosomes become associated with water
when their eggs are released into it through contamination with waste of an infected
human (Figure 22). The eggs hatch in response to fresh water to release miracidia-the
life stage of the schistosome infective to snails, the intermediate hosts of the schistosome.
Only when the permissive species of snail is present can the miracidia of a specific
species of schistosome establish an infection in the snail and continue its life cycle. At
this stage in the life of a schistosome, asexual reproduction is carried out. A miracidium
forms a primary sporocyst in the snail from which forms a secondary sporocyst. Each
secondary sporocyst gives rise to thousands of cercariae--the larval stage infective to
humans.
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Schistosome eggs are deposited in water when the water is contaminated with the waste
of an infected host (1). These eggs hatch, releasing miracidiae (2). Miracidiae infect
snails (3). Each miracidia gives rise to a primary sporocyst, which gives rise to a
secondary sporocyst (4). Cercariae are released from daughter sporocysts (5) and infect
humans by penetrating the skin (6). After penetration, the cercariae become
schistosomulae (7) and enter the circulation of the host (8). Schistosomulae mature into
adult schistosomes in the liver of the host (9). They then migrate as sexually reproducing
pairs to veins lining the intestines or bladder, depending on the species (10). (Adapted
from CDC DPDx, 2004.)
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Cercariae infect their definitive hosts by burrowing into the skin. Upon
penetration, the cercariae loose their tails to become schistosomulae which enter the host
circulatory system. The schistosomulae develop into adult worms up to 20 mm long in
approximately one month. A male and female worm pair together and reside in the
vessels lining the intestine or bladder, depending on the species of schistosome. At this
stage, the schistosomes reproduce sexually. Each pair can excrete from several hundred
to one thousand eggs everyday for an average of five years. Many of these eggs get
excreted in the urine or feces of the host to complete the cycle of infection. Many eggs
are not excreted and remain in the host causing an inflammatory response which over
time damages vital tissues of the host.
It is this very inflammatory response that some researchers have blamed for the
concurrent increases in Buruli ulcer disease and schistosomiasis. It is known that
infection with schistosomiasis drives the host immune system toward a Th2 immune
response while dampening the Thl response (77). It has been demonstrated that the
development of Buruli ulcer disease is likely to be fostered by anergy of Thl
lymphocytes (26, 27). A change from a Th 1 immune response to a Th2 response
following the development of Buruli ulcer disease has also been documented in a patient
(28). For these reasons, it has been postulated that being infected by schistosomes
predisposes patients to the development of Buruli ulcer disease (70, 87).
The following experiments were undertaken in an effort to test a different but
related hypothesis. We wanted to determine if snails, the intermediate hosts of
schistosomes, could harbor and transmit M ulcerans. Because no specific element of the
ecological niche of this bacterium had been identified at the time of these studies, it was
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thought that even negative data on this subject would be valuable. In addition, we
wanted to determine if there was an association between cercariae and M ulcerans.
Because the cercariae that infect humans must burrow into the skin, they may simply be
responsible for the penetrating injury thought to be required for M ulcerans to cause an
infection. It is plausible that M u/cerans is actually associated with the cercariae as is the
bacterium, Neorickettsia (Ehrlichia) risticii-the causative agent of Potomac horse fever
(62).

Results
Infection of Snails with M. ulcerans

In order to determine whether snails could be infected with M ulcerans,
six snails of the species Biompha/aria g/abrata were placed in 25 mL of sterile,
conditioned water to which 2.5 mL of M ulcerans 1615 culture was added. As a control,
six snails of the same species were placed in 25 mL of sterile, conditioned water to which
2.5 mL of M7H9 + OADC was added. After 24 hours, all snails in both the infection and
control groups had died. Upon examination with the naked eye and low power dissection
scope, the six snails in the infection group (I1-16) had no apparent tissue damage that
might be attributed to contact with mycolactone (or any compound within the medium).
Likewise, the six snails of the control group (Ul-U6) had no obvious change in
appearance. In preparation for the examination of the snails for an association with M
ulcerans, all snails were rinsed repeatedly with sterile water and treated with amikacin for
36 hours, which is effective at killing extracellular M ulcerans. Each snail was ground in
a sterile tissue grinder, and the homogenate was divided into two portions: one for total
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genomic DNA isolation and the other for treatment with a decontamination protocol
aimed at eliminating all bacteria other than mycobacteria. The total genomic isolations
produced a very small amount of DNA which was too dilute to be visualized via
electrophoresis. However, this DNA proved to be suitable for PCR. Total genomic DNA
isolations from all six infected snails (11-16) were PCR-positive for the 1S2404 insertion
element specific to M ulcerans; while, the total genomic DNA isolations from all six
uninfected snails (Ul -U6) were PCR-negative for 1S2404 (Figure 23). The plating of
decontaminated snail tissue resulted in a multititude of bacterial colonies diverse in
morphology {Table 3). Plates of snails 3 and 4 of the infectious group (13 and 14) and
snails 1 and 2 of the control group (Ul and U2) resulted in many colonies after two
weeks that contained acid-fast bacteria. Though M ulcerans will not grow up on a plate
in two weeks, these acid-fast colonies were analyzed via PCR for the presence of 1S2404.
None were found to be PCR-positive for this insertion element; therefore, the possibility
of them being M ulcerans was eliminated.
Infection of Schistosome-Infected Snails with M. ulcerans through 1)
Environmental Inoculation and 2) Foodborne Inoculation

In order to determine if schistosome-infected snails could be infected with
M ulcerans, two related infection studies were performed: 1) environmental infection
and 2) foodborne infection studies. For both studies, two groups of ten snails of the
species B. glabrata infected with S. mansoni were used. To allow for the schistosome
infection to develop, these snails were maintained for four weeks before infection. The
inoculum used for each of the two infections was washed with sterile water to remove
any compounds within the medium which would result in immediate death of the snails.
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Figure 23. Detection of 1S2404 via PCR in total genomic DNA isolations of M.
ulcerans-infected snails (11-16) and uninfected snails (Ul-U6).
All total genomic DNA isolations of infected snails are PCR-positive for ·1s2404,
indicative of M ulcerans; while, all total genomic DNA isolations of uninfected snails
are PCR-negative for this element.
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Table 3. Characterization of growth resulting from the plating of
decontaminated tissue from the preliminary infection of snails of the species
Biomphalaria glabrata.
Snail Plated
I

I

Infected
Group

None

12

One large, cream-colored colony appeared after two weeks.

-

13

One large, cream-colored colony appeared after two weeks.

+

!I One large, cream-colored colony appeared after two weeks.

+

Plate was overgrown with a lawn of I) cream and 2) rosei colored microorganisms that extend into the agar after one
week.
Two small areas with rose-colored growth similar to that of 15
were observed after one week. Four smooth, white colonies
were observed after four weeks. These colonies were not
morphologically similar to M ulcerans and appeared to be
yeast.
i Three large, shiny, white colonies appeared after one week.
�I I

-

14

16

Ul

I

Acid-Fast

11

15

Control
Group

Description of Growth and Time of First
Appearance

NIA

I

i

-I-

I

U2

+

U3

One smooth, shiny, yellow colony appeared after four weeks.

-

One large, shiny, white colony and a lawn of rose-colored
growth appeared after one week.

-

us
U6

I

I One large, shiny, white colony appeared after one week.
None

NIA
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i

+

Twenty large, shiny, white colonies which were
morphologically similar to those ofU l appeared after one week.

U4

I

For the environmental infection, the 10 snails of the infection group were placed in 250
mL conditioned water to which 2 mL of washed M ulcerans culture was added; while,
the 10 snails of the control group were held in 252 mL conditioned water. For the
foodborne infection, the 10 snails of the infection group were held in 250 mL conditioned
water where they were fed 1 g of food supplement which served as a matrix for the
bacteria from 2 mL of washed M ulcerans culture; while, the 10 snails of the control
group were held in 250 mL conditioned water where they were fed 1 g of sterile food
supplement. After 24 hours, all four experimental groups were returned to their
respective containers and maintained as usual for eight weeks. Both groups tolerated
infection well, and there were few premature deaths. Snails were divided relatively
equally into two groups: 1) those to be preserved for the preparation of histological slides
and 2) those to be homogenized, decontaminated, and plated.
The prepared histological sections proved to be an unreliable source of data. It
was very difficult to discern the anatomy of the snail when viewing the sections which
had been acid-fast stained. No difference between either infection group or their
respective controls could be substantiated. Many regions on every snail for both
infection studies and their respective controls had the appearance of acid-fast bacilli.
The plating of snail tissue proved to be a more valuable source of data in these
experiments. A moderate array of microorganisms survived the decontamination
procedure and grew up on the plates from snails from both infection groups as well as
their respective controls (Table 4 and Table 5). At least one representative colony from
every descriptive group of microorganisms on each plate was acid-fast stained. As noted
in Tables 4 and 5, many of these colonies were acid-fast. Colonies that were acid-fast
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Table 4. Characterization of growth resulting from the plating of decontaminated
tissue from the infection of schistosome-infected snails of the species B. glabrata with
M. ulcerans through environmental inoculation.

Snail Plated

Description of Growth and Time of First
Appearance
Many small, bright yellow colonies appeared after two
weeks.

EMul

Acid-Fast

+

I

EMu2 Many small yellow colonies morphologically identical to
those ofEMul (acid-fast); three large, shiny white colonies
(non-acid- fast); and 2 bright orange colonies (non-acid-fast)
all appeared after two weeks.
Environmentally
Infected Group

Many yellow colonies identical to those ofEmul (acid-fast);
several bright orange identical to those of EMu2 (non-acidfast); and many small white colonies (acid-fast) appeared
after two weeks.

EMu3

Emu4

I Many yellow colonies identical to those ofEmul (acid-fast);

EC2

Several bright yellow colonies identical to those of EMu 1 ,
etc. (acid-fast); several white colonies (non-acid-fast); and
several bright orange colonies identical to those of Emu2,
etc. (non-acid-fast) all appeared after 2 weeks.

EC3

Several bright yellow colonies identical to those of EMu 1,
etc. (acid-fast); several white colonies (non-acid-fast); and
several bright orange colonies identical to those of Emu2,
etc. (non-acid-fast) all appeared after 2 weeks.

I
I

Environmental
Control Group

+/-/+

+/-/-

several bright orange identical to those of EMu2 (non-acidfast); and several white colonies (non-acid-fast) all appeared
after two weeks.

1

I

+/-/-

I
EC4
1

Several bright yellow colonies identical to those of EMu 1 ,
etc. (acid-fast); several white colonies (non-acid-fast); and
several bright orange colonies identical to those ofEmu2,
etc. (non-acid-fast) all appeared after 2 weeks.
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+/-/-

+!-/-

+/-/-

Table 5. Characterization of growth resulting from the plating of decontaminated
tissue from the infection of schistosome-infected snails of the species B. glabrata with
M. ulcerans through foodborne infection.

Snail Plated
FMul

I

Acid-Fast

Description of Growth and Time of First
Appearance

I White and reddish slimy overgrowth of plate after one week.

FMu2

-

Many small, bright yellow colonies and several large, white, dry
colonies appeared after two weeks.

+/+

I
FMu3
Food
Infected
Group

+/-

Many white colonies identical to those ofFMu2 (acid-fast) and

1 a slimy lawn very similar to that of FMul (non-acid-fast)
apparent after two weeks.

FMu4

I
FMu5

Many small, yellow colonies identical to those of FMu2, etc.
(acid-fast) and eight large, shiny white colonies (non-acid-fast)
apparent after two weeks.

+/-

Similarly to those of FMu2, etc., many small, bright yellow
colonies and several large, white, dry colonies appeared after
two weeks.

+/+

I

+/+!-

FMu6 Many small, bright yellow colonies; several large, white dry
colonies; and one bright orange colony (non-acid-fast) appeared
I after two weeks.

Food
Control
Group

1
i

FCI

Several yellow colonies like those ofFMu2, etc. (acid-fast) and
one large purple colony (non-acid-fast) appeared after two
weeks.

+/-

FC2

Several yellow colonies like those ofFMu2, etc. (acid-fast) and
several white colonies (non-acid-fast) appeared after two weeks.

+!-

FC3

Similar to FMu6, many small, bright yellow colonies; several
large, white dry colonies; and several bright orange colonies
(non-acid-fast) appeared after two weeks.
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I

I
+/+!-

were analyzed via PCR for the presence of the 1S2404 insertion element used to identify
M ulcerans. None were PCR-positive for the presence of this insertion element.
Therefore, no M ulcerans was recovered from the schistosome-infected snail in either
infection study.

Discussion

In the preliminary snail infection, all snails in both the infection and control
groups died with in 24 hours. Though mycolactone is likely to be harmful to snails, this
was not the sole cause of death; because, snails in the control group did not come in
contact with mycolactone. However, all snails did come in contact with M7H9 + OADC
medium. It was clear that for any future studies designed to determine the effect of M
ulcerans on snails, the M ulcerans used must be washed clean of the media before
coming in contact with the snails.
In an effort to obtain PCR data with regard to the ability of M ulcerans to infect
snails as a part of the preliminary infection study, it was found that PCR reactions were
inhibited by the presence of even very small quantities of the ground snail tissue used as
template even after the sample was boiled. Dr. Fred Lewis of BRI reported (personal
communication) that those is his lab had been successful at isolating total DNA from
snail specimens for the purpose of PCR using the Wizard® Genomic DNA Purification
Kit. The DNA obtained from this kit was too dilute to be visualized by electrophoresis.
However, it did prove to be suitable for PCR. Because snails had been submersed in a
solution of amikacin for 36 hours, this is suggestive that the M ulcerans may be
somehow internalized. It was clear that further studies aimed at histological examination
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of the snail after a period of time sufficient enough for M ulcerans to establish an
infection would be valuable in confirming this.
It was thought that several problems with the decontamination protocol used for
plating snail tissue during this preliminary study may have resulted in the killing of M
ulcerans indicated by PCR to be present in the snails of the infection group (11-16). The
sample volumes were too small to neutralize quickly, and the pH paper proved to be an
inefficient and cumbersome way of determining when the solution was neutralized. It is
likely that the pH remained too high for too long to allow the survival of many
mycobacteria that may have been present. Despite the difficulties in decontamination,
plates of snails 3 and 4 of the infectious group (13 and 14) and snails 1 and 2 of the
control group (Ul and U2) resulted in many colonies after two weeks that were acid-fast;
however, none were confirmed to have the 1S2404 insertion element indicative of M
ulcerans. Plates were incubated for three additional months to allow for slow growing
mycobacteria to appear; however, no new colonies appeared after the first two weeks of
incubation. These colonies which had appeared had similar morphology and color and
probably represent a mycobacterium species (or other relatively slow growing acid-fast
bacterium) that is part of the normal flora of the snail. The existence of such organisms
as a part of the normal flora of B. glabrata has been reported (55).
Because snails in the natural environment in areas where Buruli ulcer is endemic
are intermediate hosts of schistosomes and play an integral role in the transmission of
schistosomiasis, it would be more valuable to examine schistosome infected snails. The
true aim of these studies is to examine any interaction between schistosome infected
snails and M ulcerans. For this reason, in the 1) environmental infection and 2) food-
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borne infection studies S. mansoni infected snails of the species B. glabrata were used.
To allow for the schistosome infection to develop, these snails were maintained for four
weeks before infection. Washing the inoculum of M ulcerans with sterile water
prevented the immediate snail death observed in the preliminary infection study.
Because the isolation of genomic DNA significantly decreases the amount of snail
homogenate available for decontamination and plating, it was determined that for these
studies no total genomic isolations would be undertaken; and thus, no snails from this
study would be evaluated via PCR. Snails were either 1) fixed and prepared in sections
or 2) ground, decontaminated, and plated. Unfortunately, the prepared sections proved to
be an unreliable source of data. It was very difficult to discern the anatomy of the snail
after acid fast staining. Many regions on every stained snail section from both infection
studies and their respective controls had the appearance of acid-fast bacilli. No
difference between either infection group or their respective controls could be
substantiated by evaluation of the histological slides made. The plating of snail tissue
proved to be a more valuable source of data in these experiments. The use of the pH
indicator solution (rather than using pH paper) allowed a more accurate and quicker
neutralization; however, no M u/cerans was recovered. It is not clear if this was due to a
still too harsh decontamination protocol or to the overgrowth of other organisms on the
plates.
During the time that this work was being done, it was determined in several other
labs that snails could not be persistently infected with M u/cerans. Further
epidemiological studies have shown no connection between schistosomiasis and Buruli
ulcer. As a result, these studies have been discontinued.
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VI. Conclusion

Efforts to create a mycolactone-negative mutant of Mycobacterium ulcerans via
transposon mutagenesis were undertaken to elucidate the genes involved in the
production of this toxin. Though only five PCR-confirmed mutants were produced, one
of these, mutant 1615:tnp6w, was confirmed to be deficient in mycolactone production
via thin-layer chromatography of acetone soluble lipids, cytopathicity assay of culture
filtrate on L929 murine fibroblasts, and mass spectroscopy of ASLs. This mutant was
found to contain an insertion near the upstream end of a gene 97% identical to the M
marinum furA gene but within a region of DNA not homologous to any other known
prokaryotic gene. It was thought that this insertion may be interrupting the transcription
of the furA homologue, because an additional mycolactone-negative mutant of M
ulcerans (mutant 97) independently created was found to have an insertion with in the
structural gene of the/urA homologue. However, the production of mycolactone was not
restored when the mutant 1615:tnp6w was transformed with a construct containing the
furA homologue of M ulcerans. PCR analysis for the presence of genes recently found
to be essential for the production of mycolactone revealed a deletion of such an essential
gene-one encoding a thioesterase (II). The absence of this gene is the most probable
and immediate cause of the mycolactone-negative phenotype. To further investigate the
role of FurA in the regulation of mycolactone production, further attempts to complement
mutant 97 should be made.
In an effort to determine the effect of temperature on the transformation
efficiency of M ulcerans via electroporation, electroporation experiments were
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performed on M ulcerans 1 6 1 5 grown in Middlebrook 7H9 with 1 0% oleic acid
albumin-dextrose-complex supplement (M7H9 + OADC). Log phase cultures were
harvested, washed with 1 0% glycerol, and apportioned into 60µL aliquots. Aliquots were
briefly held at room temperature, 37t, 40t, 45t, or 55t before electroporation in the
presence of 1 µg of pPR27H 1, a hygromycin B resistance conveying plasmid. After 6
weeks, colonies were counted to calculate transformation efficiencies. It was found that
M ulcerans cells incubated at 55t prior to electroporation had a significantly higher
transformation efficiency than those incubated at any other temperature prior to
electroporation.
To determine if the presence ofmycolactone affects electroporation efficiency, a
similar experiment was repeated with M ulcerans grown in Modified Reid's synthetic
medium and M ulcerans grown in Sauton's synthetic medium, both media which are
thought to promote a decreased production of mycolactone; M ulcerans grown in M7H9
with 20% OADC supplement (M7H9 + 2[0ADC]), which is believed to foster an
increased production of mycolactone; and, a polyketide synthase (PKS) knock-out mutant
of M ulcerans (mutant 1 1 5), which does not produce mycolactone, grown in M7H9 +
OADC . M ulcerans grown in Reid's or Sauton's synthetic media produced no
transformants. M ulcerans grown in M7H9 + 2[0ADC] had a significantly higher
transformation efficiency when incubated at 45t prior to electroporation than that grown
in M7H9 + OADC and incubated at 45t prior to electroporation. Experiments to
determine if M ulcerans grown in M7H9 + 2[0ADC] and incubated at higher
temperatures (55t and 65t) prior toelectroporation will result in even higher
electroporation efficiencies have been performed; however, the results are not available.
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Finally, though the natural reservoir of M ulcerans is unknown, Buruli ulcer
disease seems to be associated with water. For this reason, experiments aimed at
investigating aquatic snails, also associated with water in Buruli ulcer endemic regions,
as a component of the ecological niche of M ulcerans were undertaken. Snails of the
species Biomphalaria glabrata are intermediate hosts of the schistosome species
Schistosoma mansoni; and, it is feasible that M ulcerans could associate with cercariae,
the schistosomal life stage infectious to humans, infecting humans through the wound
caused by the cercaria entering its human host. Through various experiments, both
healthy Biomphalaria glabrata and Schistosoma mansoni infected Biomphalaria glabrata
were exposed to M ulcerans and examined for M ulcerans infection via PCR and plating
of ground tissue. Though PCR analysis did indicate that the M ulcerans was taken up by
the snail in some way, plating of the snail tissue as well as histological sectioning was
inconclusive. Despite decontamination protocols, there were great numbers of other
species as bacteria present on the plates which may have outcompeated the M ulcerans,
which did not grow on the plates. Slides of snails infected with M ulcerans and of
uninfected snails were indistinguishable when stained by either hematoxylin-and-eosin or
acid-fast staining. To definitively determine if there is an association between M
ulcerans and schistosome-infected snails, experiments involving fluorescently labeled
antibodies against M ulcerans or M ulcerans expressing green-fluorescent protein would
be useful.
Mycobacterium ulcerans is an organism of relatively new and fervent interests.
With Buruli ulcer having been recognized by the World Health Organism as an emerging
threat, many groups have been working to answer many of the questions addressed in the
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experiments described in this work. Significant advancements both in the identification
of the primary genes involved in the production of mycolactone and in the identification
of the ecological niche of M ulcerans have been published in the recent past.
Most recently, Stinear, et al., reported that at least many, if not all, of the essential
genes required for the production of mycolactone are located on a 174 kb plasmid that
has been named pMUM00l (73). They describe two large polyketide synthases (PKS),
MLSA 1 and MLSA2, which are responsible for the production of the 12-carbon core
lactone; while, a third PKS, MLSB, is reportedly responsible for the side chain of
mycolactone (73). The functions of these genes were assigned largely by data obtained
from transposon mutants constructed by Dr. Armand Mve-Obiang using a phage delivery
system which was found to be much more efficient at producing insertion mutants than
™

™

the EZ::TN <KAN-2>Tnp Transposome Kit used previously to construct the
mycolactone-negative mutant characterized in this work. While, still no definitive data is
available on the role of FurA in the production of mycolactone; the possibility of it
serving a regulatory role can not be ruled out.
Another important advancement in the knowledge of this organism was reported
by Marsollier, et. al and contributes to the knowledge of the ecological niche of M
ulcerans (49). This group has for the first time ever reportedly isolated M ulcerans from
the environment. The organism was found in insects collected from Bundi ulcer
endemic regions of West Africa. These insects of the genus Naucoris were found to have
salivary glands colonized by M ulcerans (49). While the biting of insects carrying M
ulcerans is likely to contribute to transmission of Buruli ulcer; other environmental
sources of this organism need to be identified. Knowing a more complete picture of the
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epidemiology of this organism will definitely prove beneficial for decreasing the incident
of Buruli ulcer and preventing outbreaks.
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